(+)-dexrazoxane increases expression ISO Bcl2l1 (Mus musculus) 6480464 Dexrazoxane results in increased expression of BCL2L1 mRNA CTD PMID:26873546 (+)-epicatechin-3-O-gallate increases expression ISO BCL2L1 (Homo sapiens) 6480464 epicatechin gallate results in increased expression of BCL2L1 protein alternative form CTD PMID:21945981 (+)-Tetrandrine decreases expression ISO BCL2L1 (Homo sapiens) 6480464 tetrandrine results in decreased expression of BCL2L1 protein CTD PMID:26822499 (-)-epigallocatechin 3-gallate multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [arsenic trioxide co-treated with epigallocatechin gallate] results in decreased expression of BCL2L1 protein more ... CTD PMID:18348186 and PMID:20950636 (1->4)-beta-D-glucan multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of BCL2L1 mRNA CTD PMID:36331819 (20R)-protopanaxadiol increases expression ISO BCL2L1 (Homo sapiens) 6480464 protopanaxadiol results in increased expression of BCL2L1 mRNA CTD PMID:31805304 (R)-carnitine multiple interactions EXP 6480464 Carnitine inhibits the reaction [Gentamicins results in decreased expression of BCL2L1 protein] CTD PMID:19491382 (R)-lipoic acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide co-treated with Thioctic Acid] results in decreased expression of BCL2L1 mRNA CTD PMID:23830814 (R)-noradrenaline decreases expression EXP 6480464 Norepinephrine results in decreased expression of BCL2L1 mRNA CTD PMID:18675472 (R)-salsolinol decreases expression EXP 6480464 salsolinol results in decreased expression of BCL2L1 protein CTD PMID:11502874 (R,R,R)-alpha-tocopherol decreases expression EXP 6480464 alpha-Tocopherol results in decreased expression of BCL2L1 protein CTD PMID:18942769 (S)-amphetamine affects expression EXP 6480464 Dextroamphetamine affects the expression of BCL2L1 mRNA alternative form CTD PMID:10336889 (S)-amphetamine multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [N-Methyl-3 and 4-methylenedioxyamphetamine co-treated with Methamphetamine co-treated with 4-methylthioamphetamine co-treated with Dextroamphetamine] results in decreased expression of BCL2L1 mRNA CTD PMID:23820845 (S)-amphetamine decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Dextroamphetamine results in decreased expression of BCL2L1 mRNA CTD PMID:23820845 (S)-colchicine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Colchicine] results in decreased expression of BCL2L1 protein CTD PMID:11749691 (S)-naringenin decreases expression ISO BCL2L1 (Homo sapiens) 6480464 naringenin results in decreased expression of BCL2L1 protein CTD PMID:27838343 (S)-nicotine multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 resveratrol inhibits the reaction [Nicotine results in decreased expression of BCL2L1 mRNA] CTD PMID:22687363 (S)-nicotine decreases expression ISO Bcl2l1 (Mus musculus) 6480464 Nicotine results in decreased expression of BCL2L1 mRNA CTD PMID:22687363 1'-acetoxychavicol acetate multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 1'-acetoxychavicol acetate inhibits the reaction [TNF protein results in increased expression of BCL2L1 protein] CTD PMID:15905586 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane decreases expression EXP 6480464 o and p'-DDT analog results in decreased expression of BCL2L1 mRNA CTD PMID:22937105 1,3-dinitrobenzene decreases response to substance ISO BCL2L1 (Homo sapiens) 6480464 BCL2L1 protein results in decreased susceptibility to 3-dinitrobenzene CTD PMID:10960601 1,3-dinitrobenzene decreases expression EXP 6480464 3-dinitrobenzene results in decreased expression of BCL2L1 mRNA CTD PMID:22841810 1,3-dinitrobenzene increases expression EXP 6480464 3-dinitrobenzene results in increased expression of BCL2L1 mRNA CTD PMID:16025311 1,3-dinitrobenzene affects response to substance EXP 6480464 BCL2L1 protein affects the susceptibility to 3-dinitrobenzene CTD PMID:16257055 1,3-Dinitropyrene decreases expression ISO Bcl2l1 (Mus musculus) 6480464 1 and 3-dinitropyrene results in decreased expression of BCL2L1 protein CTD PMID:17240030 1-bromopropane decreases expression ISO BCL2L1 (Homo sapiens) 6480464 1-bromopropane results in decreased expression of BCL2L1 mRNA CTD PMID:16815550 1-bromopropane decreases expression EXP 6480464 1-bromopropane results in decreased expression of BCL2L1 mRNA CTD PMID:16815550 1-nitropyrene decreases expression ISO Bcl2l1 (Mus musculus) 6480464 1-nitropyrene results in decreased expression of BCL2L1 protein CTD PMID:17240030 10-Hydroxycamptothecin affects response to substance ISO BCL2L1 (Homo sapiens) 6480464 BCL2L1 protein affects the susceptibility to 10-hydroxycamptothecin CTD PMID:17033717 17beta-estradiol affects expression ISO BCL2L1 (Homo sapiens) 6480464 Estradiol affects the expression of BCL2L1 mRNA CTD PMID:11896290 17beta-estradiol decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Estradiol analog results in decreased expression of BCL2L1 mRNA more ... CTD PMID:21632981 more ... 17beta-estradiol multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 EGF protein promotes the reaction [Estradiol results in decreased expression of BCL2L1 mRNA] CTD PMID:24758408 17beta-estradiol increases expression ISO BCL2L1 (Homo sapiens) 6480464 Estradiol results in increased expression of BCL2L1 mRNA and Estradiol results in increased expression of BCL2L1 protein CTD PMID:15969986 more ... 17beta-estradiol multiple interactions EXP 6480464 Estradiol inhibits the reaction [Dimethylnitrosamine results in decreased expression of BCL2L1 protein] CTD PMID:14659978 17beta-estradiol 3-benzoate affects expression EXP 6480464 estradiol 3-benzoate affects the expression of BCL2L1 mRNA CTD PMID:15664431 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO Bcl2l1 (Mus musculus) 6480464 Dihydrotestosterone results in increased expression of BCL2L1 mRNA CTD PMID:17023530 17beta-hydroxy-5alpha-androstan-3-one multiple interactions EXP 6480464 Dihydrotestosterone inhibits the reaction [Dehydroepiandrosterone results in increased expression of BCL2L1 protein] CTD PMID:16407456 1H-pyrazole decreases expression ISO Bcl2l1 (Mus musculus) 6480464 pyrazole results in decreased expression of BCL2L1 mRNA CTD PMID:33737021 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO BCL2L1 (Homo sapiens) 6480464 2 more ... CTD PMID:27589474 2,2',4,4'-Tetrabromodiphenyl ether increases expression ISO BCL2L1 (Homo sapiens) 6480464 2 more ... CTD PMID:27589474 2,2-bis(hydroxymethyl)-1-azabicyclo[2.2.2]octan-3-one decreases expression ISO BCL2L1 (Homo sapiens) 6480464 2 more ... CTD PMID:21109480 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of BCL2L1 mRNA CTD PMID:16039398 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of BCL2L1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of BCL2L1 mRNA CTD PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Bcl2l1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of BCL2L1 mRNA CTD PMID:21570461 and PMID:24680724 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO BCL2L1 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin affects the expression of BCL2L1 mRNA CTD PMID:22574217 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Bcl2l1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of BCL2L1 mRNA CTD PMID:12167310 and PMID:14718646 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of BCL2L1 mRNA and Tetrachlorodibenzodioxin results in increased expression of BCL2L1 protein CTD PMID:15965093 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of BCL2L1 mRNA and Tetrachlorodibenzodioxin results in decreased expression of BCL2L1 protein CTD PMID:15965093 and PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Bcl2l1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of BCL2L1 mRNA CTD PMID:19933214 2,4-dinitrotoluene affects expression EXP 6480464 2 and 4-dinitrotoluene affects the expression of BCL2L1 mRNA CTD PMID:21346803 2,6-dichloroindophenol multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [2 and 6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in decreased expression of BCL2L1 mRNA CTD PMID:21034357 2-acetamidofluorene multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of BCL2L1 protein and IFNA2 protein affects the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] affects the expression of BCL2L1 protein] CTD PMID:11915028 2-acetamidofluorene increases expression ISO Bcl2l1 (Mus musculus) 6480464 2-Acetylaminofluorene results in increased expression of BCL2L1 mRNA CTD PMID:21607683 2-amino-2-deoxy-D-glucopyranose decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Glucosamine results in decreased expression of BCL2L1 protein CTD PMID:15972124 and PMID:16850161 2-amino-2-deoxy-D-glucopyranose multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 pepstatin inhibits the reaction [Glucosamine results in decreased expression of BCL2L1 protein] CTD PMID:16850161 2-deoxy-D-glucose decreases response to substance ISO Bcl2l1 (Mus musculus) 6480464 BCL2L1 protein results in decreased susceptibility to Deoxyglucose CTD PMID:10679475 2-ethoxyethanol increases expression EXP 6480464 2-ethoxyethanol results in increased expression of BCL2L1 mRNA CTD PMID:19643169 2-Hydroxy-6-(8,11,14-pentadecatrienyl)benzoic acid multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 anacardic acid inhibits the reaction [TNF protein results in increased expression of BCL2L1 protein] CTD PMID:18349320 2-methoxy-17beta-estradiol decreases expression ISO Bcl2l1 (Mus musculus) 6480464 2-Methoxyestradiol results in decreased expression of BCL2L1 protein CTD PMID:36414027 2-methoxyethanol increases expression EXP 6480464 methyl cellosolve results in increased expression of BCL2L1 mRNA CTD PMID:19643169 2-palmitoylglycerol increases expression ISO BCL2L1 (Homo sapiens) 6480464 2-palmitoylglycerol results in increased expression of BCL2L1 mRNA CTD PMID:37199045 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine multiple interactions EXP 6480464 Dinoprostone affects the reaction [Puromycin Aminonucleoside results in decreased expression of BCL2L1 protein] CTD PMID:16396944 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 [Puromycin Aminonucleoside co-treated with pifithrin] results in increased expression of BCL2L1 protein and Dexamethasone inhibits the reaction [Puromycin Aminonucleoside results in decreased expression of BCL2L1 protein] CTD PMID:15987750 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine decreases expression EXP 6480464 Puromycin Aminonucleoside results in decreased expression of BCL2L1 protein CTD PMID:16396944 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine decreases expression ISO Bcl2l1 (Mus musculus) 6480464 Puromycin Aminonucleoside results in decreased expression of BCL2L1 protein CTD PMID:15987750 3,3',5-triiodo-L-thyronine increases expression ISO BCL2L1 (Homo sapiens) 6480464 Triiodothyronine results in increased expression of BCL2L1 protein CTD PMID:16021636 3,3',5-triiodo-L-thyronine increases expression EXP 6480464 Triiodothyronine results in increased expression of BCL2L1 protein CTD PMID:16021636 3,3'-diindolylmethane increases expression ISO BCL2L1 (Homo sapiens) 6480464 3 more ... CTD PMID:18025290 3,4-Methylenedioxyamphetamine affects expression EXP 6480464 3 and 4-Methylenedioxyamphetamine affects the expression of BCL2L1 mRNA alternative form CTD PMID:10336889 3,4-methylenedioxymethamphetamine affects expression EXP 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine affects the expression of BCL2L1 mRNA alternative form CTD PMID:10336889 3,4-methylenedioxymethamphetamine multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [N-Methyl-3 and 4-methylenedioxyamphetamine co-treated with Methamphetamine co-treated with 4-methylthioamphetamine co-treated with Dextroamphetamine] results in decreased expression of BCL2L1 mRNA CTD PMID:23820845 3,4-methylenedioxymethamphetamine decreases expression ISO BCL2L1 (Homo sapiens) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in decreased expression of BCL2L1 mRNA CTD PMID:23820845 3,7-dihydropurine-6-thione decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Mercaptopurine results in decreased expression of BCL2L1 protein CTD PMID:12697733 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 2 more ... CTD PMID:29704545 3-methyladenine multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 3-methyladenine inhibits the reaction [Fluorouracil results in increased expression of BCL2L1 protein] CTD PMID:19116755 3-methyladenine increases expression ISO Bcl2l1 (Mus musculus) 6480464 3-methyladenine results in increased expression of BCL2L1 mRNA CTD PMID:21681844 3-methyladenine multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 3-methyladenine inhibits the reaction [Fluorouracil results in increased expression of BCL2L1 protein] CTD PMID:19116755 3-nitropropanoic acid decreases expression EXP 6480464 3-nitropropionic acid results in decreased expression of BCL2L1 mRNA CTD PMID:21827809 3-nitropropanoic acid multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 3-nitropropionic acid inhibits the reaction [ginsenoside Re inhibits the reaction [3-Pyridinecarboxylic acid more ... CTD PMID:37308051 3-nitropropanoic acid multiple interactions EXP 6480464 Ginkgo biloba extract inhibits the reaction [3-nitropropionic acid results in decreased expression of BCL2L1 mRNA] CTD PMID:21827809 4,4'-sulfonyldiphenol decreases methylation ISO BCL2L1 (Homo sapiens) 6480464 bisphenol S results in decreased methylation of BCL2L1 gene CTD PMID:31601247 4,5,6,7-TETRABROMOBENZOTRIAZOLE multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [4 more ... CTD PMID:16489027 4-Aminobenzamide multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 4-aminobenzamide inhibits the reaction [Acetaminophen results in decreased expression of BCL2L1 protein] CTD PMID:11461765 4-hydroxynon-2-enal decreases expression ISO Bcl2l1 (Mus musculus) 6480464 4-hydroxy-2-nonenal results in decreased expression of BCL2L1 mRNA CTD PMID:19191707 4-hydroxynon-2-enal decreases expression ISO BCL2L1 (Homo sapiens) 6480464 4-hydroxy-2-nonenal results in decreased expression of BCL2L1 mRNA CTD PMID:12419474 4-hydroxyphenyl retinamide increases expression ISO Bcl2l1 (Mus musculus) 6480464 Fenretinide results in increased expression of BCL2L1 mRNA CTD PMID:28973697 4-hydroxyphenyl retinamide decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Fenretinide results in decreased expression of BCL2L1 protein CTD PMID:16187019 4-hydroxyphenyl retinamide multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [Fenretinide co-treated with Carmustine] results in decreased expression of BCL2L1 protein CTD PMID:16187019 4-nitro-m-cresol decreases expression ISO Bcl2l1 (Mus musculus) 6480464 4-nitro-3-cresol results in decreased expression of BCL2L1 protein CTD PMID:22467373 4-nitro-m-cresol multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 Quercetin inhibits the reaction [4-nitro-3-cresol results in decreased expression of BCL2L1 protein] CTD PMID:22467373 4-nitrophenol multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 Quercetin inhibits the reaction [4-nitrophenol results in decreased expression of BCL2L1 protein] CTD PMID:23997041 4-nitrophenol decreases expression ISO Bcl2l1 (Mus musculus) 6480464 4-nitrophenol results in decreased expression of BCL2L1 protein CTD PMID:23997041 4-nonylphenol decreases expression EXP 6480464 4-nonylphenol results in decreased expression of BCL2L1 mRNA and 4-nonylphenol results in decreased expression of BCL2L1 protein CTD PMID:27087316 and PMID:27109770 4-vinylcyclohexene dioxide increases expression ISO Bcl2l1 (Mus musculus) 6480464 4-vinyl-1-cyclohexene dioxide results in increased expression of BCL2L1 mRNA CTD PMID:20829426 5-aza-2'-deoxycytidine decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Decitabine results in decreased expression of BCL2L1 protein CTD PMID:19372550 5-aza-2'-deoxycytidine multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [Decitabine co-treated with Depsipeptides] results in decreased expression of BCL2L1 mRNA CTD PMID:17064661 5-azacytidine multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [metacept-1 co-treated with Azacitidine] results in decreased expression of BCL2L1 CTD PMID:19148494 5-azacytidine affects expression ISO BCL2L1 (Homo sapiens) 6480464 [Azacitidine affects the expression of IL6R protein] which affects the expression of BCL2L1 protein CTD PMID:18443271 5-fluorouracil decreases expression ISO Bcl2l1 (Mus musculus) 6480464 Fluorouracil results in decreased expression of BCL2L1 protein CTD PMID:20844880 and PMID:32270916 5-fluorouracil multiple interactions EXP 6480464 Fluorouracil inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2L1 mRNA] and Fluorouracil inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2L1 protein] CTD PMID:31129132 5-fluorouracil affects response to substance ISO BCL2L1 (Homo sapiens) 6480464 BCL2L1 protein affects the susceptibility to Fluorouracil CTD PMID:15767554 more ... 5-fluorouracil increases expression ISO BCL2L1 (Homo sapiens) 6480464 Fluorouracil results in increased expression of BCL2L1 mRNA and Fluorouracil results in increased expression of BCL2L1 protein CTD PMID:16557594 and PMID:19116755 5-fluorouracil decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Fluorouracil results in decreased expression of BCL2L1 more ... CTD PMID:12442003 more ... 5-fluorouracil affects expression ISO BCL2L1 (Homo sapiens) 6480464 Fluorouracil affects the expression of BCL2L1 mRNA and Fluorouracil affects the expression of BCL2L1 protein CTD PMID:16929163 and PMID:34151400 5-fluorouracil decreases response to substance ISO BCL2L1 (Homo sapiens) 6480464 BCL2L1 protein results in decreased susceptibility to Fluorouracil CTD PMID:17439414 5-fluorouracil multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 3-methyladenine inhibits the reaction [Fluorouracil results in increased expression of BCL2L1 protein] more ... CTD PMID:15289866 more ... 5-fluorouracil multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 3-methyladenine inhibits the reaction [Fluorouracil results in increased expression of BCL2L1 protein] more ... CTD PMID:19116755 more ... 5-fluorouracil increases expression ISO Bcl2l1 (Mus musculus) 6480464 Fluorouracil results in increased expression of BCL2L1 protein CTD PMID:19116755 5-Hydroxycapric acid multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 5-hydroxydecanoic acid inhibits the reaction [Diazoxide results in increased expression of BCL2L1 mRNA alternative form] and 5-hydroxydecanoic acid inhibits the reaction [Diazoxide results in increased expression of BCL2L1 protein alternative form] CTD PMID:15326191 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 6-chloro-2 more ... CTD PMID:21593185 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide decreases expression EXP 6480464 6-chloro-2 more ... CTD PMID:35307491 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide multiple interactions EXP 6480464 [6-chloro-2 more ... CTD PMID:35307491 6-oxocampestanol affects expression ISO BCL2L1 (Homo sapiens) 6480464 6-oxocampestanol affects the expression of BCL2L1 protein CTD PMID:32001316 7,8-diacetoxy-4-methylcoumarin decreases expression ISO BCL2L1 (Homo sapiens) 6480464 7 and 8-diacetoxy-4-methylcoumarin results in decreased expression of BCL2L1 protein CTD PMID:19061872 8-OH-DPAT decreases expression ISO Bcl2l1 (Mus musculus) 6480464 8-Hydroxy-2-(di-n-propylamino)tetralin results in decreased expression of BCL2L1 protein CTD PMID:30366073 8-OH-DPAT multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 acetovanillone inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in decreased expression of BCL2L1 protein] more ... CTD PMID:30366073 9,10-anthraquinone decreases expression ISO BCL2L1 (Homo sapiens) 6480464 9 and 10-anthraquinone analog results in decreased expression of BCL2L1 protein CTD PMID:26915975 9-Methoxycamptothecin increases expression ISO BCL2L1 (Homo sapiens) 6480464 9-methoxycamptothecin results in increased expression of BCL2L1 mRNA CTD PMID:23369935 [6]-Shogaol decreases expression ISO BCL2L1 (Homo sapiens) 6480464 shogaol results in decreased expression of BCL2L1 protein CTD PMID:18384088 ABT-737 multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 ABT-737 inhibits the reaction [BCL2L1 protein results in decreased susceptibility to Valproic Acid] and ABT-737 inhibits the reaction [BCL2L1 protein results in decreased susceptibility to Vorinostat] CTD PMID:19060243 ABT-737 multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 ABT-737 inhibits the reaction [Cholecalciferol promotes the reaction [BECN1 protein binds to BCL2L1 protein]] CTD PMID:18628207 ABT-737 increases expression ISO BCL2L1 (Homo sapiens) 6480464 ABT-737 results in increased expression of BCL2L1 protein alternative form CTD PMID:21256112 acetochlor affects expression ISO BCL2L1 (Homo sapiens) 6480464 acetochlor affects the expression of BCL2L1 protein CTD PMID:25291404 acetylsalicylic acid decreases expression ISO Bcl2l1 (Mus musculus) 6480464 Aspirin results in decreased expression of BCL2L1 protein CTD PMID:20886344 acetylsalicylic acid increases expression ISO BCL2L1 (Homo sapiens) 6480464 Aspirin results in increased expression of BCL2L1 mRNA CTD PMID:17342322 and PMID:20457246 acrylamide affects expression EXP 6480464 Acrylamide affects the expression of BCL2L1 mRNA CTD PMID:28959563 acrylonitrile decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Acrylonitrile results in decreased expression of BCL2L1 protein CTD PMID:33132245 actinomycin D decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Dactinomycin results in decreased expression of BCL2L1 protein CTD PMID:15592511 actinomycin D multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 Dexamethasone inhibits the reaction [Dactinomycin results in increased expression of BCL2L1 protein] CTD PMID:9326359 actinomycin D increases expression ISO BCL2L1 (Homo sapiens) 6480464 Dactinomycin results in increased expression of BCL2L1 protein and Dactinomycin results in increased expression of BCL2L1 protein alternative form CTD PMID:12430140 and PMID:9326359 adenosine decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Adenosine results in decreased expression of BCL2L1 mRNA and Adenosine results in decreased expression of BCL2L1 protein CTD PMID:20063052 adenosine multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 Dipyridamole inhibits the reaction [Adenosine results in decreased expression of BCL2L1 mRNA] and Dipyridamole inhibits the reaction [Adenosine results in decreased expression of BCL2L1 protein] CTD PMID:20063052 afimoxifene increases expression ISO BCL2L1 (Homo sapiens) 6480464 afimoxifene results in increased expression of BCL2L1 mRNA CTD PMID:19698761 aflatoxin B1 increases expression ISO BCL2L1 (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of BCL2L1 mRNA CTD PMID:22100608 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of BCL2L1 mRNA CTD PMID:33354967 aflatoxin B1 decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of BCL2L1 mRNA CTD PMID:28943387 aflatoxin B1 decreases methylation ISO BCL2L1 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of BCL2L1 gene CTD PMID:27153756 aflatoxin B1 decreases expression ISO Bcl2l1 (Mus musculus) 6480464 Aflatoxin B1 results in decreased expression of BCL2L1 protein CTD PMID:26968497 AH23848 multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [6-isopropoxy-9-oxoxanthene-2-carboxylic acid co-treated with AH 23848] promotes the reaction [BAD protein binds to BCL2L1 protein] more ... CTD PMID:19407222 aldehydo-D-glucosamine decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Glucosamine results in decreased expression of BCL2L1 protein CTD PMID:15972124 and PMID:16850161 aldehydo-D-glucosamine multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 pepstatin inhibits the reaction [Glucosamine results in decreased expression of BCL2L1 protein] CTD PMID:16850161 aldehydo-D-glucose multiple interactions EXP 6480464 BCL2L1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 alginic acid decreases expression ISO Bcl2l1 (Mus musculus) 6480464 Alginic Acid results in decreased expression of BCL2L1 protein CTD PMID:35066102 all-trans-retinoic acid multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 CYP26A1 protein inhibits the reaction [Tretinoin promotes the reaction [Hydrogen Peroxide results in decreased expression of BCL2L1 protein]] more ... CTD PMID:14592536 and PMID:15703382 all-trans-retinoic acid multiple interactions EXP 6480464 Mifepristone promotes the reaction [Tretinoin results in increased expression of BCL2L1 mRNA] CTD PMID:26915917 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of BCL2L1 mRNA and Tretinoin results in increased expression of BCL2L1 protein CTD PMID:26915917 all-trans-retinoic acid decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Tretinoin results in decreased expression of BCL2L1 protein CTD PMID:14592536 more ... all-trans-retinoic acid increases expression ISO Bcl2l1 (Mus musculus) 6480464 Tretinoin results in increased expression of BCL2L1 mRNA CTD PMID:22498432 all-trans-retinoic acid affects expression ISO Bcl2l1 (Mus musculus) 6480464 Tretinoin affects the expression of BCL2L1 mRNA CTD PMID:16211290 all-trans-retinoic acid increases expression ISO BCL2L1 (Homo sapiens) 6480464 Tretinoin results in increased expression of BCL2L1 protein CTD PMID:10750663 allicin multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 allicin inhibits the reaction [arsenic trioxide results in decreased expression of BCL2L1 protein] CTD PMID:27561292 alloxan decreases expression EXP 6480464 Alloxan results in decreased expression of BCL2L1 protein CTD PMID:22138235 alloxan multiple interactions EXP 6480464 Taurine inhibits the reaction [Alloxan results in decreased expression of BCL2L1 protein] CTD PMID:22138235 alpha-Solamarine multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 alpha-solamargine inhibits the reaction [Sevoflurane results in decreased expression of BCL2L1 mRNA] and alpha-solamargine inhibits the reaction [Sevoflurane results in decreased expression of BCL2L1 protein] CTD PMID:35350913 alpha-Zearalanol decreases expression ISO Bcl2l1 (Mus musculus) 6480464 Zeranol results in decreased expression of BCL2L1 protein CTD PMID:24120472 aluminium atom multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [aluminum chlorhydrate results in increased abundance of Aluminum] which results in decreased expression of BCL2L1 protein CTD PMID:31945389 aluminium oxide increases expression ISO BCL2L1 (Homo sapiens) 6480464 Aluminum Oxide analog results in increased expression of BCL2L1 mRNA CTD PMID:23132795 aluminium(0) multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [aluminum chlorhydrate results in increased abundance of Aluminum] which results in decreased expression of BCL2L1 protein CTD PMID:31945389 alvocidib multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [alvocidib co-treated with Bortezomib] results in decreased expression of BCL2L1 protein more ... CTD PMID:12517783 more ... alvocidib decreases expression ISO BCL2L1 (Homo sapiens) 6480464 alvocidib results in decreased expression of BCL2L1 more ... CTD PMID:12517783 and PMID:16820931 amino acid multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 Amino Acids inhibits the reaction [KL gene mutant form results in decreased expression of BCL2L1 protein] and H 1356 inhibits the reaction [Amino Acids inhibits the reaction [KL gene mutant form results in decreased expression of BCL2L1 protein]] CTD PMID:25309793 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of BCL2L1 mRNA CTD PMID:16483693 ammonium chloride increases expression ISO Bcl2l1 (Mus musculus) 6480464 Ammonium Chloride results in increased expression of BCL2L1 mRNA CTD PMID:31310755 ammonium chloride increases expression EXP 6480464 Ammonium Chloride results in increased expression of BCL2L1 protein CTD PMID:16483693 amosite asbestos multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 BCL2L1 protein inhibits the reaction [Asbestos more ... CTD PMID:23885834 amphibole asbestos increases expression ISO BCL2L1 (Homo sapiens) 6480464 Asbestos and Amphibole results in increased expression of BCL2L1 protein CTD PMID:20855422 amsacrine decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Amsacrine results in decreased expression of BCL2L1 protein CTD PMID:37451322 amsacrine multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [[Amsacrine results in decreased phosphorylation of MAPK1 protein] which results in decreased expression of ELAVL1 mRNA] which results in increased degradation of BCL2L1 mRNA more ... CTD PMID:37451322 anthocyanin multiple interactions EXP 6480464 Anthocyanins inhibits the reaction [Streptozocin results in decreased expression of BCL2L1 protein] CTD PMID:28856781 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [pyrazolanthrone co-treated with U 0126] inhibits the reaction [fisetin results in decreased expression of BCL2L1 protein] more ... CTD PMID:18281123 more ... anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions EXP 6480464 pyrazolanthrone inhibits the reaction [Acetaminophen results in increased expression of BCL2L1 protein modified form] CTD PMID:20166895 ANTIMYCIN increases expression ISO Bcl2l1 (Mus musculus) 6480464 antimycin results in increased expression of BCL2L1 protein CTD PMID:10463952 antirheumatic drug decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of BCL2L1 mRNA CTD PMID:24449571 Antrocin decreases expression ISO BCL2L1 (Homo sapiens) 6480464 antrocin analog results in decreased expression of BCL2L1 protein more ... CTD PMID:21158420 and PMID:36565974 AP20187 multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [AP20187 results in increased activity of INSR protein mutant form] which results in decreased expression of BCL2L1 mRNA CTD PMID:29330302 apigenin decreases expression EXP 6480464 Apigenin results in decreased expression of BCL2L1 protein CTD PMID:24144774 apigenin multiple interactions EXP 6480464 Apigenin inhibits the reaction [Isoproterenol results in decreased expression of BCL2L1 protein] CTD PMID:30152906 apocynin multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 acetovanillone inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in decreased expression of BCL2L1 protein] CTD PMID:30366073 arachidonic acid multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 1 more ... CTD PMID:19540902 more ... arachidonic acid decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Arachidonic Acid results in decreased expression of BCL2L1 protein CTD PMID:19540902 and PMID:19720122 arecoline increases expression EXP 6480464 Arecoline results in increased expression of BCL2L1 protein CTD PMID:33929070 aripiprazole multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [Aripiprazole co-treated with Ozone] results in increased expression of BCL2L1 mRNA CTD PMID:31476115 arjunolic acid multiple interactions EXP 6480464 arjunolic acid inhibits the reaction [Streptozocin results in increased expression of BCL2L1 protein] CTD PMID:19682444 arsane increases expression EXP 6480464 Arsenic results in increased expression of BCL2L1 protein CTD PMID:11756236 arsane multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] which co-treated with Benzo(a)pyrene] results in increased expression of BCL2L1 protein more ... CTD PMID:32525701 more ... arsane increases expression ISO BCL2L1 (Homo sapiens) 6480464 Arsenic results in increased expression of BCL2L1 mRNA CTD PMID:19962721 arsenic atom increases expression ISO BCL2L1 (Homo sapiens) 6480464 Arsenic results in increased expression of BCL2L1 mRNA CTD PMID:19962721 arsenic atom multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] which co-treated with Benzo(a)pyrene] results in increased expression of BCL2L1 protein more ... CTD PMID:32525701 more ... arsenic atom increases expression EXP 6480464 Arsenic results in increased expression of BCL2L1 protein CTD PMID:11756236 arsenous acid affects expression EXP 6480464 Arsenic Trioxide affects the expression of BCL2L1 protein CTD PMID:23337567 arsenous acid affects expression ISO BCL2L1 (Homo sapiens) 6480464 Arsenic Trioxide affects the expression of BCL2L1 protein CTD PMID:23770046 arsenous acid affects response to substance ISO BCL2L1 (Homo sapiens) 6480464 BCL2L1 protein affects the susceptibility to Arsenic Trioxide CTD PMID:10648417 and PMID:11468182 arsenous acid multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [salvianolic acid B inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2L1 protein]] more ... CTD PMID:23201927 and PMID:28391263 arsenous acid multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 [Genistein co-treated with Arsenic Trioxide] results in decreased expression of BCL2L1 protein more ... CTD PMID:21078540 and PMID:28587418 arsenous acid multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [Arsenic Trioxide co-treated with epigallocatechin gallate] results in decreased expression of BCL2L1 protein more ... CTD PMID:12883035 more ... arsenous acid decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of BCL2L1 mRNA and Arsenic Trioxide results in decreased expression of BCL2L1 protein CTD PMID:11739184 more ... arsenous acid decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of BCL2L1 mRNA and Arsenic Trioxide results in decreased expression of BCL2L1 protein CTD PMID:19730151 more ... arsenous acid decreases expression ISO Bcl2l1 (Mus musculus) 6480464 Arsenic Trioxide results in decreased expression of BCL2L1 mRNA and Arsenic Trioxide results in decreased expression of BCL2L1 protein CTD PMID:28454374 and PMID:28587418 arsenous acid increases expression ISO BCL2L1 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of BCL2L1 mRNA and Arsenic Trioxide results in increased expression of BCL2L1 protein CTD PMID:17530438 and PMID:23082001 atazanavir sulfate multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Atazanavir Sulfate] results in increased expression of BCL2L1 mRNA CTD PMID:33819548 Atranorin decreases expression ISO BCL2L1 (Homo sapiens) 6480464 atranorin results in decreased expression of BCL2L1 protein CTD PMID:22285236 Atranorin decreases expression ISO Bcl2l1 (Mus musculus) 6480464 atranorin results in decreased expression of BCL2L1 protein CTD PMID:26969521 atrazine affects expression EXP 6480464 Atrazine affects the expression of BCL2L1 protein CTD PMID:26075868 atrazine increases expression ISO BCL2L1 (Homo sapiens) 6480464 Atrazine results in increased expression of BCL2L1 mRNA CTD PMID:22378314 atrazine increases expression ISO Bcl2l1 (Mus musculus) 6480464 Atrazine results in increased expression of BCL2L1 protein CTD PMID:22515965 atrazine multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 [Atrazine co-treated with Chlorpyrifos co-treated with Endosulfan] results in increased expression of BCL2L1 protein CTD PMID:22515965 atrazine decreases expression EXP 6480464 Atrazine results in decreased expression of BCL2L1 mRNA and Atrazine results in decreased expression of BCL2L1 protein CTD PMID:26075868 Auriculasin decreases expression ISO BCL2L1 (Homo sapiens) 6480464 auriculasin results in decreased expression of BCL2L1 protein CTD PMID:30236598 azadirachtin A decreases expression ISO BCL2L1 (Homo sapiens) 6480464 azadirachtin results in decreased expression of BCL2L1 mRNA CTD PMID:20429769 azathioprine decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Azathioprine results in decreased expression of BCL2L1 mRNA and Azathioprine results in decreased expression of BCL2L1 protein CTD PMID:12697733 azilsartan multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [Zinc Sulfate binds to azilsartan] which results in decreased expression of BCL2L1 protein CTD PMID:29408668 Bay-K-8644 multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 3-nitropropionic acid inhibits the reaction [ginsenoside Re inhibits the reaction [3-Pyridinecarboxylic acid more ... CTD PMID:37308051 Bay-K-8644 decreases expression ISO Bcl2l1 (Mus musculus) 6480464 3-Pyridinecarboxylic acid more ... CTD PMID:37308051 benzene multiple interactions EXP 6480464 [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of BCL2L1 mRNA CTD PMID:17905399 benzene decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Benzene results in decreased expression of BCL2L1 mRNA CTD PMID:33064461 benzo[a]pyrene decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of BCL2L1 mRNA and Benzo(a)pyrene results in decreased expression of BCL2L1 protein CTD PMID:15698582 more ... benzo[a]pyrene increases expression ISO BCL2L1 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of BCL2L1 mRNA CTD PMID:32234424 benzo[a]pyrene multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] which co-treated with Benzo(a)pyrene] results in increased expression of BCL2L1 protein CTD PMID:32802178 benzo[a]pyrene increases expression ISO Bcl2l1 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of BCL2L1 mRNA CTD PMID:18656336 more ... benzo[a]pyrene diol epoxide I decreases expression ISO BCL2L1 (Homo sapiens) 6480464 7 more ... CTD PMID:19150397 and PMID:20018196 Benzo[a]pyrene-7,8-diol decreases expression ISO BCL2L1 (Homo sapiens) 6480464 benzo(a)pyrene 7 and 8-dihydrodiol results in decreased expression of BCL2L1 protein CTD PMID:15698582 benzo[b]fluoranthene increases expression ISO BCL2L1 (Homo sapiens) 6480464 benzo(b)fluoranthene results in increased expression of BCL2L1 protein CTD PMID:21776270 benzophenanthridine decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Benzophenanthridines analog results in decreased expression of BCL2L1 mRNA CTD PMID:23117580 benzothiazoles decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Benzothiazoles metabolite results in decreased expression of BCL2L1 mRNA CTD PMID:23339777 Berbamine decreases expression ISO BCL2L1 (Homo sapiens) 6480464 berbamine results in decreased expression of BCL2L1 protein CTD PMID:19960011 berberine decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Berberine results in decreased expression of BCL2L1 protein CTD PMID:16505103 beta-D-glucan decreases expression ISO BCL2L1 (Homo sapiens) 6480464 beta-Glucans results in decreased expression of BCL2L1 mRNA CTD PMID:25970150 beta-D-glucosamine decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Glucosamine results in decreased expression of BCL2L1 protein CTD PMID:15972124 and PMID:16850161 beta-D-glucosamine multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 pepstatin inhibits the reaction [Glucosamine results in decreased expression of BCL2L1 protein] CTD PMID:16850161 Beta-Solamarine decreases expression ISO BCL2L1 (Homo sapiens) 6480464 beta-solamarine results in decreased expression of BCL2L1 protein CTD PMID:17619073 bicalutamide decreases expression ISO BCL2L1 (Homo sapiens) 6480464 bicalutamide results in decreased expression of BCL2L1 protein CTD PMID:28500234 bicalutamide multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 bicalutamide promotes the reaction [Niclosamide results in decreased expression of BCL2L1 protein] and Niclosamide promotes the reaction [bicalutamide results in decreased expression of BCL2L1 protein] CTD PMID:28500234 bilirubin IXalpha multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 Bilirubin promotes the reaction [Iron-Dextran Complex results in increased expression of BCL2L1 protein] CTD PMID:20709802 biochanin A decreases expression ISO BCL2L1 (Homo sapiens) 6480464 biochanin A results in decreased expression of BCL2L1 protein CTD PMID:12791511 bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of BCL2L1 mRNA and Diethylhexyl Phthalate results in decreased expression of BCL2L1 protein CTD PMID:37979351 bis(2-ethylhexyl) phthalate multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 GW 6471 inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of BCL2L1 protein] CTD PMID:37979351 bis(2-ethylhexyl) phthalate decreases expression ISO Bcl2l1 (Mus musculus) 6480464 Diethylhexyl Phthalate results in decreased expression of BCL2L1 protein CTD PMID:37979351 bisphenol A multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of BCL2L1 protein more ... CTD PMID:19270784 more ... bisphenol A decreases expression ISO BCL2L1 (Homo sapiens) 6480464 bisphenol A results in decreased expression of BCL2L1 protein CTD PMID:34664771 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of BCL2L1 mRNA CTD PMID:34947998 bisphenol A multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 [Caffeine co-treated with bisphenol A] results in decreased expression of BCL2L1 mRNA CTD PMID:31756439 bisphenol A affects expression ISO BCL2L1 (Homo sapiens) 6480464 bisphenol A affects the expression of BCL2L1 mRNA CTD PMID:30903817 bisphenol A decreases expression ISO Bcl2l1 (Mus musculus) 6480464 bisphenol A results in decreased expression of BCL2L1 mRNA CTD PMID:32407858 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of BCL2L1 mRNA CTD PMID:27539358 bisphenol A increases expression ISO Bcl2l1 (Mus musculus) 6480464 bisphenol A results in increased expression of BCL2L1 mRNA CTD PMID:26049153 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of BCL2L1 mRNA CTD PMID:25181051 and PMID:32145629 bisphenol A increases expression ISO BCL2L1 (Homo sapiens) 6480464 bisphenol A results in increased expression of BCL2L1 mRNA and bisphenol A results in increased expression of BCL2L1 protein CTD PMID:19270784 more ... Bisphenol A diglycidyl ether multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 2 more ... CTD PMID:32408695 boric acid decreases expression ISO BCL2L1 (Homo sapiens) 6480464 boric acid results in decreased expression of BCL2L1 mRNA CTD PMID:34175401 bortezomib multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [alvocidib co-treated with Bortezomib] results in decreased expression of BCL2L1 protein more ... CTD PMID:15039284 more ... bortezomib decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Bortezomib results in decreased expression of BCL2L1 mRNA and Bortezomib results in decreased expression of BCL2L1 protein CTD PMID:15543232 more ... bortezomib increases expression ISO BCL2L1 (Homo sapiens) 6480464 Bortezomib results in increased expression of BCL2L1 protein CTD PMID:17326159 bortezomib increases cleavage ISO BCL2L1 (Homo sapiens) 6480464 Bortezomib results in increased cleavage of BCL2L1 protein CTD PMID:16118318 bortezomib decreases response to substance ISO BCL2L1 (Homo sapiens) 6480464 BCL2L1 protein results in decreased susceptibility to Bortezomib CTD PMID:15781649 and PMID:19100720 brassinin decreases expression ISO BCL2L1 (Homo sapiens) 6480464 brassinin analog results in decreased expression of BCL2L1 mRNA CTD PMID:24747292 brassinolide decreases expression ISO BCL2L1 (Homo sapiens) 6480464 brassinolide results in decreased expression of BCL2L1 protein CTD PMID:20833159 Bromoenol lactone multiple interactions EXP 6480464 6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2H-pyran-2-one inhibits the reaction [Thapsigargin affects the splicing of BCL2L1 mRNA] CTD PMID:25762722 Brusatol decreases expression ISO BCL2L1 (Homo sapiens) 6480464 brusatol results in decreased expression of BCL2L1 protein CTD PMID:33465425 buta-1,3-diene increases expression ISO Bcl2l1 (Mus musculus) 6480464 1 and 3-butadiene results in increased expression of BCL2L1 mRNA CTD PMID:29038090 butein decreases expression ISO Bcl2l1 (Mus musculus) 6480464 butein results in decreased expression of BCL2L1 protein CTD PMID:11055382 Butylparaben increases expression ISO BCL2L1 (Homo sapiens) 6480464 butylparaben results in increased expression of BCL2L1 mRNA and butylparaben results in increased expression of BCL2L1 protein CTD PMID:24481588 C60 fullerene decreases expression EXP 6480464 fullerene C60 results in decreased expression of BCL2L1 mRNA CTD PMID:19167457 cadmium atom multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with fenvalerate] results in increased expression of BCL2L1 protein and BCL2L1 protein inhibits the reaction [Cadmium affects the localization of DNASE2 protein] CTD PMID:22677345 and PMID:28949029 cadmium atom increases expression EXP 6480464 Cadmium results in increased expression of BCL2L1 protein CTD PMID:25388156 cadmium atom affects expression EXP 6480464 Cadmium affects the expression of BCL2L1 mRNA and Cadmium affects the expression of BCL2L1 protein CTD PMID:25388156 cadmium atom increases cleavage ISO BCL2L1 (Homo sapiens) 6480464 Cadmium results in increased cleavage of BCL2L1 protein CTD PMID:10970901 cadmium dichloride decreases expression ISO Bcl2l1 (Mus musculus) 6480464 Cadmium Chloride results in decreased expression of BCL2L1 mRNA and Cadmium Chloride results in decreased expression of BCL2L1 protein CTD PMID:15501611 and PMID:21337715 cadmium dichloride affects expression EXP 6480464 Cadmium Chloride affects the expression of BCL2L1 mRNA CTD PMID:35525383 cadmium dichloride decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Cadmium Chloride results in decreased expression of BCL2L1 mRNA CTD PMID:33813002 cadmium dichloride multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with fenvalerate] results in increased expression of BCL2L1 protein more ... CTD PMID:28949029 more ... cadmium dichloride increases expression ISO BCL2L1 (Homo sapiens) 6480464 Cadmium Chloride results in increased expression of BCL2L1 mRNA and Cadmium Chloride results in increased expression of BCL2L1 protein CTD PMID:27510461 and PMID:34520792 cadmium dichloride multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 Quercetin inhibits the reaction [Cadmium Chloride results in decreased expression of BCL2L1 protein] CTD PMID:21337715 cafestol decreases expression ISO BCL2L1 (Homo sapiens) 6480464 cafestol results in decreased expression of BCL2L1 protein CTD PMID:21334318 caffeine multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 [Caffeine co-treated with bisphenol A] results in decreased expression of BCL2L1 mRNA CTD PMID:31756439 Calcimycin decreases response to substance EXP 6480464 BCL2L1 gene mutant form results in decreased susceptibility to Calcimycin CTD PMID:10970895 calciol multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [Cholecalciferol results in increased phosphorylation of BAD protein] inhibits the reaction [BAD protein binds to BCL2L1 protein] more ... CTD PMID:18628207 calciol increases expression ISO BCL2L1 (Homo sapiens) 6480464 Cholecalciferol results in increased expression of BCL2L1 protein CTD PMID:18628207 calcitriol increases expression EXP 6480464 Calcitriol results in increased expression of BCL2L1 protein CTD PMID:17570329 calcitriol decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Calcitriol results in decreased expression of BCL2L1 protein CTD PMID:10614618 and PMID:12479363 calyculin a multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 calyculin A inhibits the reaction [[Ibuprofen co-treated with epigallocatechin gallate] results in decreased expression of BCL2L1 mRNA alternative form] and calyculin A inhibits the reaction [[Ibuprofen co-treated with epigallocatechin gallate] results in increased expression of BCL2L1 mRNA alternative form] CTD PMID:18348186 camalexin decreases expression ISO BCL2L1 (Homo sapiens) 6480464 camalexin metabolite results in decreased expression of BCL2L1 mRNA CTD PMID:23339777 camptothecin decreases response to substance ISO BCL2L1 (Homo sapiens) 6480464 BCL2L1 mRNA results in decreased susceptibility to Camptothecin CTD PMID:25269479 camptothecin multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 Folic Acid inhibits the reaction [Camptothecin results in decreased expression of BCL2L1 mRNA] CTD PMID:30581319 camptothecin decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Camptothecin results in decreased expression of BCL2L1 mRNA CTD PMID:30581319 camptothecin multiple interactions EXP 6480464 Dexamethasone inhibits the reaction [Camptothecin results in decreased expression of BCL2L1 protein alternative form] more ... CTD PMID:19339209 and PMID:19497415 camptothecin increases expression EXP 6480464 Camptothecin results in increased expression of BCL2L1 protein CTD PMID:19497415 camptothecin decreases expression EXP 6480464 Camptothecin results in decreased expression of BCL2L1 protein alternative form CTD PMID:19339209 camptothecin decreases response to substance EXP 6480464 BCL2L1 gene mutant form results in decreased susceptibility to Camptothecin CTD PMID:10970895 Candesartan cilexetil increases expression EXP 6480464 candesartan cilexetil results in increased expression of BCL2L1 protein CTD PMID:22120037 cannabidiol increases expression ISO Bcl2l1 (Mus musculus) 6480464 Cannabidiol results in increased expression of BCL2L1 mRNA CTD PMID:33019509 cannabidiol decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Cannabidiol results in decreased expression of BCL2L1 mRNA CTD PMID:30713602 cannabidiol multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [Cannabidiol co-treated with moringin] results in increased expression of BCL2L1 mRNA and [Cannabidiol results in increased expression of MIR1972-2 mRNA] which results in decreased expression of BCL2L1 mRNA CTD PMID:30096889 and PMID:30713602 cannabigerol increases expression ISO Bcl2l1 (Mus musculus) 6480464 cannabigerol results in increased expression of BCL2L1 mRNA CTD PMID:33019509 capillarisin multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 Bortezomib promotes the reaction [capillarisin results in decreased expression of BCL2L1 protein] CTD PMID:24333736 capillarisin decreases expression ISO BCL2L1 (Homo sapiens) 6480464 capillarisin results in decreased expression of BCL2L1 mRNA and capillarisin results in decreased expression of BCL2L1 protein CTD PMID:24333736 capsaicin decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Capsaicin results in decreased expression of BCL2L1 protein CTD PMID:17505005 capsaicin increases expression ISO BCL2L1 (Homo sapiens) 6480464 Capsaicin results in increased expression of BCL2L1 mRNA CTD PMID:19502594 carbamazepine affects expression ISO BCL2L1 (Homo sapiens) 6480464 Carbamazepine affects the expression of BCL2L1 mRNA CTD PMID:24752500 carbon nanotube affects expression ISO Bcl2l1 (Mus musculus) 6480464 Nanotubes and Carbon analog affects the expression of BCL2L1 mRNA CTD PMID:25554681 carbon nanotube increases expression ISO Bcl2l1 (Mus musculus) 6480464 Nanotubes and Carbon results in increased expression of BCL2L1 mRNA CTD PMID:25554681 carbonyl cyanide p-trifluoromethoxyphenylhydrazone decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone results in decreased expression of BCL2L1 mRNA CTD PMID:16039398 carboplatin decreases expression ISO Bcl2l1 (Mus musculus) 6480464 Carboplatin results in decreased expression of BCL2L1 protein CTD PMID:18483861 carboplatin multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [Carboplatin results in decreased expression of BCL2L1 protein] CTD PMID:18483861 carmustine affects response to substance ISO BCL2L1 (Homo sapiens) 6480464 BCL2L1 protein affects the susceptibility to Carmustine CTD PMID:15332326 carmustine decreases expression EXP 6480464 Carmustine results in decreased expression of BCL2L1 protein CTD PMID:19860839 carmustine multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [Fenretinide co-treated with Carmustine] results in decreased expression of BCL2L1 protein CTD PMID:16187019 carmustine decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Carmustine results in decreased expression of BCL2L1 mRNA and Carmustine results in decreased expression of BCL2L1 protein CTD PMID:15332326 carvedilol increases expression EXP 6480464 carvedilol results in increased expression of BCL2L1 protein CTD PMID:20079142 casticin decreases expression ISO BCL2L1 (Homo sapiens) 6480464 casticin results in decreased expression of BCL2L1 protein CTD PMID:27862857 and PMID:29098808 casticin decreases expression ISO Bcl2l1 (Mus musculus) 6480464 casticin results in decreased expression of BCL2L1 protein CTD PMID:32270916 casticin multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 casticin promotes the reaction [Fluorouracil results in decreased expression of BCL2L1 protein] and Fluorouracil promotes the reaction [casticin results in decreased expression of BCL2L1 protein] CTD PMID:32270916 casticin increases expression ISO BCL2L1 (Homo sapiens) 6480464 casticin results in increased expression of BCL2L1 mRNA CTD PMID:27862857 cefaloridine affects expression EXP 6480464 Cephaloridine affects the expression of BCL2L1 mRNA CTD PMID:18172885 celecoxib multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [Celecoxib co-treated with docetaxel] results in decreased expression of BCL2L1 protein more ... CTD PMID:15688368 and PMID:20104024 celecoxib increases expression ISO BCL2L1 (Homo sapiens) 6480464 Celecoxib results in increased expression of BCL2L1 mRNA CTD PMID:17342322 celecoxib decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Celecoxib results in decreased expression of BCL2L1 protein CTD PMID:15688368 cetrorelix decreases expression ISO BCL2L1 (Homo sapiens) 6480464 cetrorelix results in decreased expression of BCL2L1 protein CTD PMID:21062912 chenodeoxycholic acid multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of BCL2L1 mRNA more ... CTD PMID:33819548 chenodeoxycholic acid multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 Chenodeoxycholic Acid promotes the reaction [Carbon Tetrachloride results in decreased expression of BCL2L1 mRNA] CTD PMID:25747392 chloroprene increases expression ISO Bcl2l1 (Mus musculus) 6480464 Chloroprene results in increased expression of BCL2L1 mRNA CTD PMID:23125180 chloroquine multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 BCL2L1 mutant form promotes the reaction [Chloroquine results in increased activity of CASP3 protein] CTD PMID:11589424 chloroquine increases expression ISO Bcl2l1 (Mus musculus) 6480464 Chloroquine results in increased expression of BCL2L1 mRNA CTD PMID:31310755 chlorpromazine increases expression ISO Bcl2l1 (Mus musculus) 6480464 Chlorpromazine results in increased expression of BCL2L1 mRNA CTD PMID:21683644 chlorpyrifos multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 [Atrazine co-treated with Chlorpyrifos co-treated with Endosulfan] results in increased expression of BCL2L1 protein CTD PMID:22515965 chlorpyrifos increases expression ISO Bcl2l1 (Mus musculus) 6480464 Chlorpyrifos results in increased expression of BCL2L1 mRNA and Chlorpyrifos results in increased expression of BCL2L1 protein CTD PMID:22515965 more ... cholesterol multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 Cholesterol inhibits the reaction [arachidonyl dopamine results in decreased expression of BCL2L1 mRNA] CTD PMID:33393692 choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency] results in decreased expression of BCL2L1 protein and geraniol inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in decreased expression of BCL2L1 protein] CTD PMID:26695085 chromium(6+) decreases expression ISO BCL2L1 (Homo sapiens) 6480464 chromium hexavalent ion results in decreased expression of BCL2L1 protein CTD PMID:16166740 chromium(6+) multiple interactions EXP 6480464 [6-chloro-2 more ... CTD PMID:35307491 chromium(6+) increases expression ISO BCL2L1 (Homo sapiens) 6480464 chromium hexavalent ion results in increased expression of BCL2L1 protein CTD PMID:25448439 and PMID:29069462 chromium(6+) multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 Luteolin inhibits the reaction [chromium hexavalent ion results in increased expression of BCL2L1 protein] and TP53 protein affects the reaction [chromium hexavalent ion results in decreased expression of BCL2L1 protein] CTD PMID:16166740 and PMID:25448439 chrysazin increases expression ISO BCL2L1 (Homo sapiens) 6480464 danthron results in increased expression of BCL2L1 protein CTD PMID:21126053 chrysazin decreases expression ISO BCL2L1 (Homo sapiens) 6480464 danthron results in decreased expression of BCL2L1 protein CTD PMID:21126053 chrysin multiple interactions EXP 6480464 chrysin inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2L1 mRNA] and chrysin inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2L1 protein] CTD PMID:21167192 chrysin 5,7-dimethyl ether multiple interactions EXP 6480464 5 and 7-dimethoxyflavone inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2L1 protein] CTD PMID:21554863 ciguatoxin CTX1B affects expression ISO Bcl2l1 (Mus musculus) 6480464 Ciguatoxins affects the expression of BCL2L1 mRNA CTD PMID:18353800 Cirsimarin decreases expression ISO BCL2L1 (Homo sapiens) 6480464 cirsimarin results in decreased expression of BCL2L1 mRNA CTD PMID:35710092 cisplatin multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [Cisplatin co-treated with acetyl-11-ketoboswellic acid] results in decreased expression of BCL2L1 protein more ... CTD PMID:15917659 more ... cisplatin increases expression ISO Bcl2l1 (Mus musculus) 6480464 Cisplatin results in increased expression of BCL2L1 mRNA and Cisplatin results in increased expression of BCL2L1 protein CTD PMID:19833167 more ... cisplatin multiple interactions EXP 6480464 SB 203580 promotes the reaction [Cisplatin results in decreased expression of BCL2L1 protein] CTD PMID:19578154 cisplatin decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Cisplatin results in decreased expression of BCL2L1 mRNA and Cisplatin results in decreased expression of BCL2L1 protein CTD PMID:17399942 more ... cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of BCL2L1 mRNA and Cisplatin results in decreased expression of BCL2L1 protein CTD PMID:18172885 and PMID:19578154 cisplatin decreases expression ISO Bcl2l1 (Mus musculus) 6480464 Cisplatin results in decreased expression of BCL2L1 more ... CTD PMID:21593185 and PMID:26193055 cisplatin multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 6-chloro-2 more ... CTD PMID:19833167 more ... cisplatin increases expression ISO BCL2L1 (Homo sapiens) 6480464 Cisplatin results in increased expression of BCL2L1 protein CTD PMID:17619073 cisplatin increases degradation ISO BCL2L1 (Homo sapiens) 6480464 Cisplatin results in increased degradation of BCL2L1 protein CTD PMID:21821001 cisplatin decreases response to substance ISO BCL2L1 (Homo sapiens) 6480464 BCL2L1 protein results in decreased susceptibility to Cisplatin and BCL2L1 results in decreased susceptibility to Cisplatin CTD PMID:16020667 and PMID:21849418 citric acid multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [Citric Acid co-treated with zinc chloride] results in decreased expression of BCL2L1 protein CTD PMID:16624386 Clivoline decreases expression ISO BCL2L1 (Homo sapiens) 6480464 clivorine results in decreased expression of BCL2L1 protein CTD PMID:19437449 Clivoline multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 EGF protein inhibits the reaction [clivorine results in decreased expression of BCL2L1 protein] CTD PMID:19437449 clofarabine multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [clofarabine co-treated with resveratrol] inhibits the reaction [BCL2L1 mutant form results in increased expression of MCL1 protein] more ... CTD PMID:25408576 clofibrate multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 Clofibrate inhibits the reaction [[Fatty Acids and Nonesterified binds to ALB protein] which results in decreased expression of BCL2L1 protein] CTD PMID:21338618 clofibrate increases expression ISO Bcl2l1 (Mus musculus) 6480464 Clofibrate results in increased expression of BCL2L1 protein CTD PMID:21338618 clonidine increases expression EXP 6480464 Clonidine results in increased expression of BCL2L1 mRNA CTD PMID:12423672 clonidine (amino form) increases expression EXP 6480464 Clonidine results in increased expression of BCL2L1 mRNA CTD PMID:12423672 clonidine (imino form) increases expression EXP 6480464 Clonidine results in increased expression of BCL2L1 mRNA CTD PMID:12423672 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of BCL2L1 mRNA CTD PMID:18442013 cobalt dichloride multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 2 more ... CTD PMID:32408695 cobalt dichloride multiple interactions EXP 6480464 scutellarin inhibits the reaction [cobaltous chloride results in decreased expression of BCL2L1 mRNA] CTD PMID:18442013 cocaine increases expression EXP 6480464 Cocaine results in increased expression of BCL2L1 mRNA and Cocaine results in increased expression of BCL2L1 mRNA alternative form CTD PMID:16076954 cocaine multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 IL6 protein affects the reaction [Cocaine results in decreased expression of BCL2L1 protein] more ... CTD PMID:29673861 and PMID:30393195 cocaine decreases expression ISO Bcl2l1 (Mus musculus) 6480464 Cocaine results in decreased expression of BCL2L1 protein CTD PMID:29673861 and PMID:30393195 coenzyme Q10 multiple interactions EXP 6480464 coenzyme Q10 inhibits the reaction [Doxorubicin results in decreased expression of BCL2L1 protein] CTD PMID:27087047 colistin multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 Sirolimus inhibits the reaction [Colistin results in decreased expression of BCL2L1 protein] CTD PMID:35378205 colistin decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Colistin results in decreased expression of BCL2L1 protein CTD PMID:35378205 copper atom multiple interactions EXP 6480464 [Copper co-treated with pyrrolidine dithiocarbamic acid] results in decreased expression of BCL2L1 protein and Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in decreased expression of BCL2L1 protein] CTD PMID:22085843 copper atom decreases expression ISO Bcl2l1 (Mus musculus) 6480464 Copper analog results in decreased expression of BCL2L1 protein CTD PMID:21319953 copper(0) multiple interactions EXP 6480464 [Copper co-treated with pyrrolidine dithiocarbamic acid] results in decreased expression of BCL2L1 protein and Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in decreased expression of BCL2L1 protein] CTD PMID:22085843 copper(0) decreases expression ISO Bcl2l1 (Mus musculus) 6480464 Copper analog results in decreased expression of BCL2L1 protein CTD PMID:21319953 copper(II) chloride decreases expression ISO Bcl2l1 (Mus musculus) 6480464 cupric chloride results in decreased expression of BCL2L1 protein CTD PMID:23313662 and PMID:24170445 cordycepin decreases expression ISO BCL2L1 (Homo sapiens) 6480464 cordycepin results in decreased expression of BCL2L1 protein CTD PMID:21310227 cordycepin multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 Acetylcysteine inhibits the reaction [cordycepin results in decreased expression of BCL2L1 protein] CTD PMID:21310227 corticosterone multiple interactions EXP 6480464 [Corticosterone results in increased expression of BCL2L1 protein] which results in decreased susceptibility to Doxorubicin more ... CTD PMID:15755911 more ... corticosterone increases expression EXP 6480464 Corticosterone results in increased expression of BCL2L1 mRNA and Corticosterone results in increased expression of BCL2L1 protein CTD PMID:15755911 more ... crocidolite asbestos increases expression EXP 6480464 Asbestos and Crocidolite results in increased expression of BCL2L1 mRNA CTD PMID:12909582 crocidolite asbestos decreases expression ISO Bcl2l1 (Mus musculus) 6480464 Asbestos and Crocidolite results in decreased expression of BCL2L1 mRNA CTD PMID:29279043 crocidolite asbestos affects expression ISO BCL2L1 (Homo sapiens) 6480464 Asbestos and Crocidolite affects the expression of BCL2L1 mRNA CTD PMID:17331233 CU-O LINKAGE decreases expression ISO BCL2L1 (Homo sapiens) 6480464 cupric oxide results in decreased expression of BCL2L1 mRNA CTD PMID:32285662 cucurbitacin E decreases expression ISO BCL2L1 (Homo sapiens) 6480464 cucurbitacin E results in decreased expression of BCL2L1 protein CTD PMID:27106530 curcumin multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [Curcumin co-treated with Doxorubicin] affects the expression of BCL2L1 mRNA more ... CTD PMID:15911101 more ... curcumin decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Curcumin analog results in decreased expression of BCL2L1 mRNA more ... CTD PMID:12497104 more ... curcumin decreases expression ISO Bcl2l1 (Mus musculus) 6480464 Curcumin results in decreased expression of BCL2L1 protein CTD PMID:18829502 curcumin multiple interactions EXP 6480464 Curcumin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2L1 protein] CTD PMID:15569404 curcumin multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 [Curcumin co-treated with Gemcitabine] results in decreased expression of BCL2L1 protein CTD PMID:17440100 curcumin increases expression ISO BCL2L1 (Homo sapiens) 6480464 Curcumin results in increased expression of BCL2L1 mRNA CTD PMID:15911101 cycloheximide increases expression ISO BCL2L1 (Homo sapiens) 6480464 Cycloheximide results in increased expression of BCL2L1 protein alternative form CTD PMID:9326359 cycloheximide multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 Dexamethasone inhibits the reaction [Cycloheximide results in increased expression of BCL2L1 protein] CTD PMID:9326359 cyclophosphamide increases expression EXP 6480464 Cyclophosphamide results in increased expression of BCL2L1 mRNA CTD PMID:11599041 cyclophosphamide decreases expression ISO Bcl2l1 (Mus musculus) 6480464 Cyclophosphamide results in decreased expression of BCL2L1 mRNA CTD PMID:33737021 cyclosporin A affects expression ISO BCL2L1 (Homo sapiens) 6480464 Cyclosporine affects the expression of BCL2L1 mRNA CTD PMID:20106945 cyclosporin A multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 Cyclosporine inhibits the reaction [3-Pyridinecarboxylic acid more ... CTD PMID:37308051 cyclosporin A multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Cyclosporine] results in increased expression of BCL2L1 mRNA CTD PMID:33819548 cyclosporin A increases expression ISO BCL2L1 (Homo sapiens) 6480464 Cyclosporine results in increased expression of BCL2L1 mRNA CTD PMID:25562108 cyclosporin A decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of BCL2L1 mRNA CTD PMID:21632981 cylindrospermopsin increases expression ISO BCL2L1 (Homo sapiens) 6480464 cylindrospermopsin results in increased expression of BCL2L1 mRNA CTD PMID:23726867 and PMID:24921660 cypermethrin decreases expression EXP 6480464 cypermethrin results in decreased expression of BCL2L1 protein CTD PMID:22048644 cypermethrin decreases expression ISO Bcl2l1 (Mus musculus) 6480464 cypermethrin results in decreased expression of BCL2L1 mRNA CTD PMID:34714723 cypermethrin increases expression ISO BCL2L1 (Homo sapiens) 6480464 cypermethrin results in increased expression of BCL2L1 mRNA CTD PMID:27704156 cypermethrin multiple interactions EXP 6480464 HBEGF protein inhibits the reaction [cypermethrin results in decreased expression of BCL2L1 protein] CTD PMID:22048644 cytarabine multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 BCL2L1 protein inhibits the reaction [Cytarabine results in increased cleavage of and results in increased activity of CASP3 protein] and BCL2L1 protein inhibits the reaction [Cytarabine results in increased degradation of PARP1 protein] CTD PMID:8840993 D-glucose multiple interactions EXP 6480464 BCL2L1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 dactolisib affects expression ISO BCL2L1 (Homo sapiens) 6480464 dactolisib affects the expression of BCL2L1 protein CTD PMID:25640480 daidzein decreases expression ISO BCL2L1 (Homo sapiens) 6480464 daidzein results in decreased expression of BCL2L1 protein CTD PMID:12791511 deguelin decreases expression ISO BCL2L1 (Homo sapiens) 6480464 deguelin results in decreased expression of BCL2L1 mRNA and deguelin results in decreased expression of BCL2L1 protein CTD PMID:19365708 more ... deguelin multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 deguelin inhibits the reaction [TNF protein results in increased expression of BCL2L1 mRNA] CTD PMID:22623043 dehydroepiandrosterone increases expression EXP 6480464 Dehydroepiandrosterone results in increased expression of BCL2L1 protein CTD PMID:16407456 dehydroepiandrosterone multiple interactions EXP 6480464 Dexamethasone inhibits the reaction [Dehydroepiandrosterone results in increased expression of BCL2L1 protein] more ... CTD PMID:16407456 dehydroepiandrosterone sulfate increases expression EXP 6480464 Dehydroepiandrosterone Sulfate results in increased expression of BCL2L1 protein CTD PMID:16407456 dehydroepiandrosterone sulfate multiple interactions EXP 6480464 Pertussis Toxin inhibits the reaction [Dehydroepiandrosterone Sulfate results in increased expression of BCL2L1 protein] CTD PMID:16407456 delphinidin decreases expression ISO BCL2L1 (Homo sapiens) 6480464 delphinidin results in decreased expression of BCL2L1 protein CTD PMID:33955636 demethoxycurcumin decreases expression ISO BCL2L1 (Homo sapiens) 6480464 demethoxycurcumin results in decreased expression of BCL2L1 mRNA and demethoxycurcumin results in decreased expression of BCL2L1 protein CTD PMID:33582110 and PMID:34291863 demethoxyfumitremorgin C decreases expression ISO BCL2L1 (Homo sapiens) 6480464 demethoxyfumitremorgin C results in decreased expression of BCL2L1 protein CTD PMID:28359723 deoxycholic acid multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of BCL2L1 mRNA more ... CTD PMID:33819548 deoxynivalenol decreases expression ISO BCL2L1 (Homo sapiens) 6480464 deoxynivalenol results in decreased expression of BCL2L1 mRNA CTD PMID:22846391 depsipeptide multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [decitabine co-treated with Depsipeptides] results in decreased expression of BCL2L1 mRNA CTD PMID:17064661 Destruxin B multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 Sorafenib promotes the reaction [destruxin B results in decreased expression of BCL2L1 protein] CTD PMID:24434019 Destruxin B decreases expression ISO BCL2L1 (Homo sapiens) 6480464 destruxin B results in decreased expression of BCL2L1 protein CTD PMID:22465936 and PMID:24434019 dexamethasone multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 Dexamethasone inhibits the reaction [Cisplatin results in decreased expression of BCL2L1 mRNA] more ... CTD PMID:21940343 and PMID:9326359 dexamethasone decreases expression EXP 6480464 Dexamethasone results in decreased expression of BCL2L1 protein CTD PMID:30506661 dexamethasone increases expression ISO Bcl2l1 (Mus musculus) 6480464 Dexamethasone results in increased expression of BCL2L1 mRNA CTD PMID:22733784 dexamethasone decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Dexamethasone results in decreased expression of BCL2L1 protein CTD PMID:15804364 and PMID:19428934 dexamethasone increases expression ISO BCL2L1 (Homo sapiens) 6480464 Dexamethasone results in increased expression of BCL2L1 mRNA alternative form and Dexamethasone results in increased expression of BCL2L1 protein alternative form CTD PMID:11319611 and PMID:17070682 dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of BCL2L1 mRNA alternative form more ... CTD PMID:10200566 more ... dexamethasone multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 2 more ... CTD PMID:15987750 and PMID:29704545 dexamethasone multiple interactions EXP 6480464 Dexamethasone inhibits the reaction [Camptothecin results in decreased expression of BCL2L1 protein alternative form] more ... CTD PMID:16407456 more ... dexamethasone increases stability ISO BCL2L1 (Homo sapiens) 6480464 Dexamethasone results in increased stability of BCL2L1 mRNA CTD PMID:9326359 dexmedetomidine multiple interactions EXP 6480464 atipamezole inhibits the reaction [Dexmedetomidine inhibits the reaction [lipopolysaccharide more ... CTD PMID:30597158 dextromethorphan multiple interactions EXP 6480464 Dizocilpine Maleate inhibits the reaction [Dextromethorphan results in decreased expression of BCL2L1 protein] and traxoprodil mesylate inhibits the reaction [Dextromethorphan results in decreased expression of BCL2L1 protein] CTD PMID:28916251 dextromethorphan decreases expression EXP 6480464 Dextromethorphan results in decreased expression of BCL2L1 protein CTD PMID:28916251 diallyl trisulfide decreases expression ISO BCL2L1 (Homo sapiens) 6480464 diallyl trisulfide results in decreased expression of BCL2L1 protein CTD PMID:17513609 and PMID:20055834 diarsenic trioxide decreases expression ISO Bcl2l1 (Mus musculus) 6480464 Arsenic Trioxide results in decreased expression of BCL2L1 mRNA and Arsenic Trioxide results in decreased expression of BCL2L1 protein CTD PMID:28454374 and PMID:28587418 diarsenic trioxide affects expression EXP 6480464 Arsenic Trioxide affects the expression of BCL2L1 protein CTD PMID:23337567 diarsenic trioxide multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [salvianolic acid B inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2L1 protein]] more ... CTD PMID:23201927 and PMID:28391263 diarsenic trioxide multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [Arsenic Trioxide co-treated with epigallocatechin gallate] results in decreased expression of BCL2L1 protein more ... CTD PMID:12883035 more ... diarsenic trioxide affects response to substance ISO BCL2L1 (Homo sapiens) 6480464 BCL2L1 protein affects the susceptibility to Arsenic Trioxide CTD PMID:10648417 and PMID:11468182 diarsenic trioxide decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Arsenic Trioxide results in decreased expression of BCL2L1 mRNA and Arsenic Trioxide results in decreased expression of BCL2L1 protein CTD PMID:11739184 more ... diarsenic trioxide affects expression ISO BCL2L1 (Homo sapiens) 6480464 Arsenic Trioxide affects the expression of BCL2L1 protein CTD PMID:23770046 diarsenic trioxide multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 [Genistein co-treated with Arsenic Trioxide] results in decreased expression of BCL2L1 protein more ... CTD PMID:21078540 and PMID:28587418 diarsenic trioxide increases expression ISO BCL2L1 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of BCL2L1 mRNA and Arsenic Trioxide results in increased expression of BCL2L1 protein CTD PMID:17530438 and PMID:23082001 diarsenic trioxide decreases expression EXP 6480464 Arsenic Trioxide results in decreased expression of BCL2L1 mRNA and Arsenic Trioxide results in decreased expression of BCL2L1 protein CTD PMID:19730151 more ... diazinon affects expression EXP 6480464 Diazinon affects the expression of BCL2L1 mRNA CTD PMID:22546817 diazoxide multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 5-hydroxydecanoic acid inhibits the reaction [Diazoxide results in increased expression of BCL2L1 mRNA alternative form] and 5-hydroxydecanoic acid inhibits the reaction [Diazoxide results in increased expression of BCL2L1 protein alternative form] CTD PMID:15326191 diazoxide increases expression ISO BCL2L1 (Homo sapiens) 6480464 Diazoxide results in increased expression of BCL2L1 mRNA alternative form and Diazoxide results in increased expression of BCL2L1 protein alternative form CTD PMID:15326191 dibenz[a,h]anthracene decreases expression ISO BCL2L1 (Homo sapiens) 6480464 1 more ... CTD PMID:16269432 dibenzo[a,l]pyrene decreases expression ISO BCL2L1 (Homo sapiens) 6480464 dibenzo(a and l)pyrene results in decreased expression of BCL2L1 mRNA CTD PMID:16269432 diclofenac increases expression ISO BCL2L1 (Homo sapiens) 6480464 Diclofenac results in increased expression of BCL2L1 mRNA alternative form CTD PMID:14609740 diclofenac affects expression ISO BCL2L1 (Homo sapiens) 6480464 Diclofenac affects the expression of BCL2L1 mRNA CTD PMID:24752500 Dictamnine decreases expression ISO BCL2L1 (Homo sapiens) 6480464 dictamnine results in decreased expression of BCL2L1 mRNA CTD PMID:34861243 dieldrin affects expression EXP 6480464 Dieldrin affects the expression of BCL2L1 mRNA CTD PMID:22546817 diethyl phthalate decreases expression ISO Bcl2l1 (Mus musculus) 6480464 diethyl phthalate results in decreased expression of BCL2L1 protein CTD PMID:37942807 diethylstilbestrol decreases expression ISO Bcl2l1 (Mus musculus) 6480464 Diethylstilbestrol results in decreased expression of BCL2L1 mRNA CTD PMID:15545218 dimethylarsinic acid increases expression ISO BCL2L1 (Homo sapiens) 6480464 Cacodylic Acid results in increased expression of BCL2L1 mRNA CTD PMID:17720352 dioscin decreases expression ISO BCL2L1 (Homo sapiens) 6480464 dioscin results in decreased expression of BCL2L1 mRNA and dioscin results in decreased expression of BCL2L1 protein CTD PMID:22334414 more ... diosgenin decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Diosgenin results in decreased expression of BCL2L1 protein CTD PMID:16331273 diosgenin multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 Diosgenin inhibits the reaction [TNF protein results in increased expression of BCL2L1 protein] CTD PMID:16331273 dioxygen decreases expression EXP 6480464 Oxygen deficiency results in decreased expression of BCL2L1 mRNA and Oxygen deficiency results in decreased expression of BCL2L1 protein CTD PMID:11042672 dioxygen multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 3 more ... CTD PMID:23452621 dioxygen increases expression ISO BCL2L1 (Homo sapiens) 6480464 Oxygen deficiency results in increased expression of BCL2L1 mRNA CTD PMID:23452621 dioxygen multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of BCL2L1 mRNA and Oxygen inhibits the reaction [Oxygen deficiency results in increased expression of BCL2L1 mRNA] CTD PMID:22629407 and PMID:30529165 dioxygen increases expression ISO Bcl2l1 (Mus musculus) 6480464 Oxygen deficiency results in increased expression of BCL2L1 mRNA CTD PMID:22629407 dioxygen multiple interactions EXP 6480464 BCL2L1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] more ... CTD PMID:11042672 and PMID:21124846 dipyridamole multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 Dipyridamole inhibits the reaction [Adenosine results in decreased expression of BCL2L1 mRNA] and Dipyridamole inhibits the reaction [Adenosine results in decreased expression of BCL2L1 protein] CTD PMID:20063052 diquat increases expression ISO Bcl2l1 (Mus musculus) 6480464 Diquat results in increased expression of BCL2L1 mRNA CTD PMID:36851058 disulfiram decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Disulfiram results in decreased expression of BCL2L1 mRNA CTD PMID:34182011 dizocilpine maleate multiple interactions EXP 6480464 Dizocilpine Maleate inhibits the reaction [Dextromethorphan results in decreased expression of BCL2L1 protein] CTD PMID:28916251 dorsomorphin decreases expression ISO BCL2L1 (Homo sapiens) 6480464 dorsomorphin results in decreased expression of BCL2L1 protein CTD PMID:31900833 dorsomorphin multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 [dorsomorphin inhibits the reaction [ADIPOQ protein results in increased expression of BCL2L1 protein]] which results in increased activity of CASP3 protein and dorsomorphin inhibits the reaction [ADIPOQ protein results in increased expression of BCL2L1 protein] CTD PMID:20709802 dorsomorphin multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 and PMID:31900833 doxorubicin increases expression ISO BCL2L1 (Homo sapiens) 6480464 Doxorubicin results in increased expression of BCL2L1 mRNA and Doxorubicin results in increased expression of BCL2L1 protein CTD PMID:15939500 more ... doxorubicin affects expression ISO BCL2L1 (Homo sapiens) 6480464 Doxorubicin affects the expression of BCL2L1 mRNA CTD PMID:31470548 doxorubicin increases expression ISO Bcl2l1 (Mus musculus) 6480464 Doxorubicin results in increased expression of BCL2L1 mRNA CTD PMID:15485691 more ... doxorubicin decreases expression ISO Bcl2l1 (Mus musculus) 6480464 Doxorubicin results in decreased expression of BCL2L1 protein CTD PMID:17673183 and PMID:20144634 doxorubicin decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of BCL2L1 mRNA and Doxorubicin results in decreased expression of BCL2L1 protein CTD PMID:16843435 more ... doxorubicin decreases response to substance ISO BCL2L1 (Homo sapiens) 6480464 BCL2L1 protein results in decreased susceptibility to Doxorubicin CTD PMID:11468182 and PMID:15781649 doxorubicin affects response to substance ISO BCL2L1 (Homo sapiens) 6480464 BCL2L1 protein affects the susceptibility to Doxorubicin CTD PMID:17923112 doxorubicin decreases ubiquitination EXP 6480464 Doxorubicin results in decreased ubiquitination of BCL2L1 protein CTD PMID:12967636 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of BCL2L1 mRNA and Doxorubicin results in decreased expression of BCL2L1 protein CTD PMID:14736733 more ... doxorubicin multiple interactions EXP 6480464 [Corticosterone results in increased expression of BCL2L1 protein] which results in decreased susceptibility to Doxorubicin more ... CTD PMID:15755911 more ... doxorubicin multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 Doxycycline inhibits the reaction [Doxorubicin results in decreased expression of BCL2L1 protein] and Silymarin inhibits the reaction [Doxorubicin results in decreased expression of BCL2L1 protein] CTD PMID:17673183 and PMID:20144634 doxorubicin affects expression ISO Bcl2l1 (Mus musculus) 6480464 Doxorubicin affects the expression of BCL2L1 mRNA CTD PMID:16439991 doxorubicin decreases response to substance ISO Bcl2l1 (Mus musculus) 6480464 BCL2L1 protein results in decreased susceptibility to Doxorubicin CTD PMID:16439991 doxorubicin multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of BCL2L1 protein] inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein] more ... CTD PMID:15289866 more ... doxycycline multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 Doxycycline inhibits the reaction [Doxorubicin results in decreased expression of BCL2L1 protein] CTD PMID:17673183 elemental selenium increases expression ISO BCL2L1 (Homo sapiens) 6480464 Selenium results in increased expression of BCL2L1 mRNA CTD PMID:19244175 elemental selenium multiple interactions EXP 6480464 [Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of BCL2L1 mRNA CTD PMID:11444866 endosulfan increases expression ISO Bcl2l1 (Mus musculus) 6480464 Endosulfan results in increased expression of BCL2L1 protein CTD PMID:22515965 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of BCL2L1 mRNA CTD PMID:29391264 endosulfan multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 [Atrazine co-treated with Chlorpyrifos co-treated with Endosulfan] results in increased expression of BCL2L1 protein CTD PMID:22515965 entinostat decreases expression ISO Bcl2l1 (Mus musculus) 6480464 entinostat results in decreased expression of BCL2L1 protein CTD PMID:21041383 erdosteine multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 erdosteine inhibits the reaction [Cisplatin results in decreased expression of BCL2L1 mRNA] and erdosteine inhibits the reaction [Cisplatin results in decreased expression of BCL2L1 protein] CTD PMID:26193055 Erionite decreases expression ISO Bcl2l1 (Mus musculus) 6480464 erionite results in decreased expression of BCL2L1 mRNA CTD PMID:29279043 esculetin multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [esculetin co-treated with Paclitaxel] results in decreased expression of BCL2L1 protein CTD PMID:16051289 esculetin decreases expression ISO BCL2L1 (Homo sapiens) 6480464 esculetin results in decreased expression of BCL2L1 protein CTD PMID:26388407 etacrynic acid increases expression ISO BCL2L1 (Homo sapiens) 6480464 Ethacrynic Acid results in increased expression of BCL2L1 protein CTD PMID:23082001 etacrynic acid multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [arsenic trioxide co-treated with Ethacrynic Acid] results in increased expression of BCL2L1 protein CTD PMID:23082001 ethanol multiple interactions EXP 6480464 Ethanol promotes the reaction [BAX protein binds to BCL2L1 protein] and salvianolic acid B inhibits the reaction [Ethanol results in decreased expression of BCL2L1 protein] CTD PMID:16035105 and PMID:24769256 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of BCL2L1 mRNA and Ethanol results in decreased expression of BCL2L1 protein CTD PMID:16098508 and PMID:24769256 ethanol affects localization EXP 6480464 Ethanol affects the localization of BCL2L1 protein CTD PMID:16035105 etoposide multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of BCL2L1 protein] inhibits the reaction [Etoposide results in increased activity of CASP3 protein] more ... CTD PMID:10620629 more ... etoposide affects expression ISO BCL2L1 (Homo sapiens) 6480464 Etoposide affects the expression of BCL2L1 protein CTD PMID:15215046 etoposide decreases response to substance ISO BCL2L1 (Homo sapiens) 6480464 BCL2L1 protein results in decreased susceptibility to Etoposide CTD PMID:11468182 eugenol multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of BCL2L1 mRNA] CTD PMID:20434464 Evodiamine multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 evodiamine inhibits the reaction [TNF protein results in increased expression of BCL2L1 protein] CTD PMID:15710601 farrerol decreases expression ISO BCL2L1 (Homo sapiens) 6480464 farrerol results in decreased expression of BCL2L1 mRNA and farrerol results in decreased expression of BCL2L1 protein CTD PMID:35833306 fenofibrate decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Fenofibrate results in decreased expression of BCL2L1 mRNA CTD PMID:20520642 fenvalerate multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with fenvalerate] results in increased expression of BCL2L1 protein CTD PMID:28949029 finasteride multiple interactions EXP 6480464 Finasteride inhibits the reaction [Testosterone results in increased expression of BCL2L1 protein] CTD PMID:25714330 fisetin decreases expression ISO BCL2L1 (Homo sapiens) 6480464 fisetin results in decreased expression of BCL2L1 protein CTD PMID:31044527 fisetin multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [pyrazolanthrone co-treated with U 0126] inhibits the reaction [fisetin results in decreased expression of BCL2L1 protein] more ... CTD PMID:31044527 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of BCL2L1 mRNA CTD PMID:18035473 flavonoids decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Flavonoids results in decreased expression of BCL2L1 mRNA and Flavonoids results in decreased expression of BCL2L1 protein CTD PMID:24036141 flubendazole increases phosphorylation ISO BCL2L1 (Homo sapiens) 6480464 flubendazole results in increased phosphorylation of BCL2L1 protein CTD PMID:32652169 flufenoxuron decreases expression ISO Bcl2l1 (Mus musculus) 6480464 flufenoxuron results in decreased expression of BCL2L1 protein CTD PMID:33771252 fluoxetine increases expression EXP 6480464 Fluoxetine results in increased expression of BCL2L1 mRNA and Fluoxetine results in increased expression of BCL2L1 protein CTD PMID:21852994 fluoxetine decreases expression EXP 6480464 Fluoxetine results in decreased expression of BCL2L1 protein CTD PMID:19298536 fluoxetine affects expression EXP 6480464 Fluoxetine affects the expression of BCL2L1 mRNA CTD PMID:21740920 flutamide decreases expression ISO Bcl2l1 (Mus musculus) 6480464 Flutamide results in decreased expression of BCL2L1 mRNA CTD PMID:19442681 folic acid decreases expression ISO Bcl2l1 (Mus musculus) 6480464 Folic Acid results in decreased expression of BCL2L1 protein CTD PMID:16595132 folic acid multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 Folic Acid inhibits the reaction [Camptothecin results in decreased expression of BCL2L1 mRNA] and Folic Acid inhibits the reaction [Doxorubicin results in decreased expression of BCL2L1 mRNA] CTD PMID:30581319 folic acid increases expression ISO Bcl2l1 (Mus musculus) 6480464 Folic Acid results in increased expression of BCL2L1 mRNA CTD PMID:25629700 folic acid multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 Folic Acid inhibits the reaction [[APP protein mutant form co-treated with PSEN1 protein mutant form co-treated with MAPT protein mutant form] results in decreased expression of BCL2L1 protein] and TNF protein affects the reaction [Folic Acid results in decreased expression of BCL2L1 protein] CTD PMID:16595132 and PMID:29068127 fructose decreases expression EXP 6480464 Fructose results in decreased expression of BCL2L1 protein CTD PMID:33475235 fructose multiple interactions EXP 6480464 Plant Extracts inhibits the reaction [Fructose results in decreased expression of BCL2L1 protein] CTD PMID:33475235 fucoxanthin multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 Acetylcysteine inhibits the reaction [fucoxanthin results in decreased expression of BCL2L1 protein] CTD PMID:20594983 fucoxanthin decreases expression ISO BCL2L1 (Homo sapiens) 6480464 fucoxanthin results in decreased expression of BCL2L1 protein CTD PMID:20594983 fulvestrant multiple interactions EXP 6480464 fulvestrant inhibits the reaction [dan-shen root extract inhibits the reaction [IGF2 protein mutant form results in increased expression of BCL2L1 protein]] CTD PMID:23419388 furan increases methylation EXP 6480464 furan results in increased methylation of BCL2L1 gene CTD PMID:22079235 furan increases expression EXP 6480464 furan results in increased expression of BCL2L1 mRNA CTD PMID:25539665 Fusarenone X increases expression ISO Bcl2l1 (Mus musculus) 6480464 fusarenon-X results in increased expression of BCL2L1 mRNA CTD PMID:24983900 galangin decreases expression ISO BCL2L1 (Homo sapiens) 6480464 galangin results in decreased expression of BCL2L1 protein CTD PMID:25450235 gallein multiple interactions EXP 6480464 gallein inhibits the reaction [N(6)-cyclopentyladenosine results in increased expression of BCL2L1 protein] CTD PMID:35901927 gamma-aminobutyric acid increases expression EXP 6480464 gamma-Aminobutyric Acid results in increased expression of BCL2L1 protein CTD PMID:29708300 gamma-aminobutyric acid decreases expression EXP 6480464 gamma-Aminobutyric Acid results in decreased expression of BCL2L1 mRNA CTD PMID:26924987 gamma-hexachlorocyclohexane multiple interactions EXP 6480464 Ro 31-8220 inhibits the reaction [Hexachlorocyclohexane results in increased expression of BCL2L1 protein] and TEMPO inhibits the reaction [Hexachlorocyclohexane results in increased expression of BCL2L1 protein] CTD PMID:22001173 gamma-hexachlorocyclohexane increases expression EXP 6480464 Hexachlorocyclohexane results in increased expression of BCL2L1 protein CTD PMID:19041923 and PMID:22001173 gamma-tocopherol decreases response to substance ISO BCL2L1 (Homo sapiens) 6480464 BCL2L1 protein results in decreased susceptibility to Tocopherols CTD PMID:16001965 Gastrodin increases expression ISO Bcl2l1 (Mus musculus) 6480464 gastrodin results in increased expression of BCL2L1 mRNA CTD PMID:23578476 geldanamycin decreases response to substance ISO BCL2L1 (Homo sapiens) 6480464 BCL2L1 protein results in decreased susceptibility to geldanamycin CTD PMID:15781649 geldanamycin multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [geldanamycin co-treated with Bortezomib] results in decreased expression of BCL2L1 protein CTD PMID:15781649 gemcitabine multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 Gemcitabine inhibits the reaction [Fluorouracil affects the expression of BCL2L1 mRNA] and Gemcitabine inhibits the reaction [Fluorouracil affects the expression of BCL2L1 protein] CTD PMID:16929163 gemcitabine decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Gemcitabine results in decreased expression of BCL2L1 protein CTD PMID:15476743 gemcitabine multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 [Curcumin co-treated with Gemcitabine] results in decreased expression of BCL2L1 protein CTD PMID:17440100 genistein multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [Genistein co-treated with arsenic trioxide] results in decreased expression of BCL2L1 protein and Genistein promotes the reaction [arsenic trioxide results in decreased expression of BCL2L1 protein] CTD PMID:18546268 and PMID:21078540 genistein decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Genistein results in decreased expression of BCL2L1 protein CTD PMID:12791511 more ... genistein decreases expression ISO Bcl2l1 (Mus musculus) 6480464 Genistein results in decreased expression of BCL2L1 mRNA and Genistein results in decreased expression of BCL2L1 protein CTD PMID:21048042 and PMID:21078540 genistein multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 [Genistein co-treated with arsenic trioxide] results in decreased expression of BCL2L1 protein CTD PMID:21078540 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of BCL2L1 protein CTD PMID:17132701 and PMID:19491382 gentamycin decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Gentamicins results in decreased expression of BCL2L1 mRNA CTD PMID:29992668 gentamycin multiple interactions EXP 6480464 Carnitine inhibits the reaction [Gentamicins results in decreased expression of BCL2L1 protein] more ... CTD PMID:17132701 more ... geraniol multiple interactions EXP 6480464 geraniol inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in decreased expression of BCL2L1 protein] and geraniol inhibits the reaction [Isoproterenol results in decreased expression of BCL2L1 mRNA] CTD PMID:26695085 and PMID:35608392 Ginkgoic acid decreases expression ISO BCL2L1 (Homo sapiens) 127284886 Ginkgoic acid decreases expression of BCL2L1 mRNA and protein in stomach RGD Ginkgolide C multiple interactions EXP 6480464 ginkgolide C inhibits the reaction [Paraquat results in decreased expression of BCL2L1 protein] CTD PMID:35707280 ginsenoside Re multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 3-nitropropionic acid inhibits the reaction [ginsenoside Re inhibits the reaction [3-Pyridinecarboxylic acid more ... CTD PMID:37308051 glucose multiple interactions EXP 6480464 BCL2L1 protein results in decreased susceptibility to [Oxygen deficiency co-treated with Glucose deficiency] CTD PMID:21124846 glutathione multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 Glutathione inhibits the reaction [Curcumin inhibits the reaction [TNF protein results in increased expression of BCL2L1 protein]] CTD PMID:17640567 glycochenodeoxycholic acid multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of BCL2L1 mRNA more ... CTD PMID:33819548 glycocholic acid multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of BCL2L1 mRNA more ... CTD PMID:33819548 glycodeoxycholic acid multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of BCL2L1 mRNA more ... CTD PMID:33819548 glyphosate decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Glyphosate results in decreased expression of BCL2L1 protein CTD PMID:30907447 glyphosate increases expression ISO Bcl2l1 (Mus musculus) 6480464 Glyphosate results in increased expression of BCL2L1 mRNA CTD PMID:35897073 glyphosate increases expression ISO BCL2L1 (Homo sapiens) 6480464 Glyphosate results in increased expression of BCL2L1 mRNA CTD PMID:17984146 gold atom multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [Polyethyleneimine binds to Gold] which results in increased expression of BCL2L1 mRNA CTD PMID:28433809 gold(0) multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [Polyethyleneimine binds to Gold] which results in increased expression of BCL2L1 mRNA CTD PMID:28433809 gossypin decreases expression ISO BCL2L1 (Homo sapiens) 6480464 gossypin results in decreased expression of BCL2L1 protein CTD PMID:30536456 gossypol multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 Gossypol analog binds to and affects the activity of BCL2L1 protein CTD PMID:16020667 gossypol decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Gossypol results in decreased expression of BCL2L1 protein CTD PMID:18840529 GW 6471 multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 GW 6471 inhibits the reaction [ADIPOQ protein results in increased expression of BCL2L1 protein] and GW 6471 inhibits the reaction [Diethylhexyl Phthalate results in decreased expression of BCL2L1 protein] CTD PMID:20709802 and PMID:37979351 Gyrophoric acid decreases expression ISO BCL2L1 (Homo sapiens) 6480464 gyrophoric acid results in decreased expression of BCL2L1 protein CTD PMID:22285236 haloperidol multiple interactions EXP 6480464 EPO protein inhibits the reaction [Haloperidol results in decreased expression of BCL2L1 protein] CTD PMID:17805306 haloperidol increases expression EXP 6480464 Haloperidol results in increased expression of BCL2L1 protein CTD PMID:16462815 haloperidol decreases expression EXP 6480464 Haloperidol results in decreased expression of BCL2L1 protein CTD PMID:17805306 homoeriodictyol multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 homoeriodictyol inhibits the reaction [Hydrogen Peroxide affects the expression of BCL2L1 protein] CTD PMID:29902531 hyaluronic acid multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [[[[Hyaluronic Acid binds to CD44 protein] which results in increased expression of and results in increased activity of EP300 protein] which results in increased acetylation of and results in increased activity of CTNNB1 protein] which results in increased expression of BCL2L1 protein] inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein] more ... CTD PMID:19047049 hydrogen peroxide decreases expression EXP 6480464 Hydrogen Peroxide results in decreased expression of BCL2L1 mRNA and Hydrogen Peroxide results in decreased expression of BCL2L1 protein CTD PMID:14505808 and PMID:25726415 hydrogen peroxide decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Hydrogen Peroxide results in decreased expression of BCL2L1 protein CTD PMID:15703382 more ... hydrogen peroxide multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 Acetylcysteine inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2L1 protein] more ... CTD PMID:15142122 more ... hydrogen peroxide affects expression ISO BCL2L1 (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of BCL2L1 protein CTD PMID:21179406 and PMID:29902531 hydrogen peroxide decreases response to substance EXP 6480464 BCL2L1 gene mutant form results in decreased susceptibility to Hydrogen Peroxide CTD PMID:10970895 hydrogen peroxide increases expression EXP 6480464 Hydrogen Peroxide results in increased expression of BCL2L1 mRNA CTD PMID:14689451 hydrogen peroxide multiple interactions EXP 6480464 GATA5 protein promotes the reaction [Nitric Oxide inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2L1 mRNA]] more ... CTD PMID:14505808 and PMID:25726415 hydroquinone decreases expression ISO BCL2L1 (Homo sapiens) 6480464 hydroquinone results in decreased expression of BCL2L1 protein CTD PMID:23288922 hydroquinone increases expression ISO BCL2L1 (Homo sapiens) 6480464 hydroquinone results in increased expression of BCL2L1 protein CTD PMID:35561756 hydroxamic acid decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Hydroxamic Acids analog results in decreased expression of BCL2L1 protein CTD PMID:26088127 hydroxyurea decreases response to substance EXP 6480464 BCL2L1 gene mutant form results in decreased susceptibility to Hydroxyurea CTD PMID:10970895 ibrutinib decreases expression ISO BCL2L1 (Homo sapiens) 6480464 ibrutinib results in decreased expression of BCL2L1 mRNA CTD PMID:26254443 ibuprofen multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [Ibuprofen co-treated with epigallocatechin gallate] results in decreased expression of BCL2L1 mRNA alternative form more ... CTD PMID:18348186 idelalisib multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [FASLG protein co-treated with idelalisib] results in decreased expression of BCL2L1 protein and AKT activator SC79 inhibits the reaction [[FASLG protein co-treated with idelalisib] results in decreased expression of BCL2L1 protein] CTD PMID:31445927 Idoxifene multiple interactions EXP 6480464 idoxifene inhibits the reaction [Dimethylnitrosamine results in decreased expression of BCL2L1 protein] CTD PMID:14659978 Ilimaquinone decreases expression ISO BCL2L1 (Homo sapiens) 6480464 ilimaquinone results in decreased expression of BCL2L1 protein CTD PMID:24930757 indirubin-3'-monoxime multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in increased expression of BCL2L1 mRNA CTD PMID:18958680 indole-3-methanol decreases expression ISO BCL2L1 (Homo sapiens) 6480464 indole-3-carbinol results in decreased expression of BCL2L1 and indole-3-carbinol results in decreased expression of BCL2L1 protein CTD PMID:16082211 and PMID:29992829 indometacin decreases expression EXP 6480464 Indomethacin results in decreased expression of BCL2L1 mRNA CTD PMID:19220725 indometacin decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Indomethacin results in decreased expression of BCL2L1 protein CTD PMID:11062132 and PMID:16572323 indometacin multiple interactions EXP 6480464 Melatonin inhibits the reaction [Indomethacin results in decreased expression of BCL2L1 mRNA] CTD PMID:19220725 inulin multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of BCL2L1 mRNA CTD PMID:36331819 irinotecan decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Irinotecan results in decreased expression of BCL2L1 mRNA CTD PMID:16432164 irinotecan multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 Irinotecan promotes the reaction [AS602868 results in decreased expression of BCL2L1 mRNA] CTD PMID:18182997 iron atom multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [Arachidonic Acid co-treated with Iron] results in decreased expression of BCL2L1 protein more ... CTD PMID:19620254 more ... iron dextran multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 [ADIPOQ protein results in increased expression of BCL2L1 protein] inhibits the reaction [Iron-Dextran Complex results in increased activity of CASP3 protein] more ... CTD PMID:20709802 iron dextran increases expression ISO Bcl2l1 (Mus musculus) 6480464 Iron-Dextran Complex results in increased expression of BCL2L1 protein CTD PMID:20709802 iron(0) multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [Arachidonic Acid co-treated with Iron] results in decreased expression of BCL2L1 protein more ... CTD PMID:19620254 more ... isoflavones multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [Curcumin co-treated with Isoflavones] results in decreased expression of BCL2L1 protein CTD PMID:18640131 isoflurane affects expression EXP 6480464 Isoflurane affects the expression of BCL2L1 protein CTD PMID:25597859 Isoliensinine multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 isoliensinine inhibits the reaction [RELA protein binds to BCL2L1 promoter] CTD PMID:26389520 Isoliensinine decreases expression ISO Bcl2l1 (Mus musculus) 6480464 isoliensinine results in decreased expression of BCL2L1 mRNA and isoliensinine results in decreased expression of BCL2L1 protein CTD PMID:26389520 Isoliensinine decreases expression ISO BCL2L1 (Homo sapiens) 6480464 isoliensinine results in decreased expression of BCL2L1 mRNA and isoliensinine results in decreased expression of BCL2L1 protein CTD PMID:26389520 Isoliensinine multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 isoliensinine inhibits the reaction [RELA protein binds to BCL2L1 promoter] CTD PMID:26389520 isoliquiritigenin decreases expression ISO BCL2L1 (Homo sapiens) 6480464 isoliquiritigenin results in decreased expression of BCL2L1 protein CTD PMID:15729620 isoliquiritigenin decreases expression ISO Bcl2l1 (Mus musculus) 6480464 isoliquiritigenin results in decreased expression of BCL2L1 protein CTD PMID:11055382 isoliquiritigenin decreases phosphorylation ISO BCL2L1 (Homo sapiens) 6480464 isoliquiritigenin results in decreased phosphorylation of BCL2L1 protein CTD PMID:23747687 isopimaric acid decreases expression ISO Bcl2l1 (Mus musculus) 6480464 isopimaric acid results in decreased expression of BCL2L1 protein CTD PMID:36754215 isoprenaline increases expression ISO Bcl2l1 (Mus musculus) 6480464 Isoproterenol results in increased expression of BCL2L1 mRNA CTD PMID:20003209 isoprenaline decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Isoproterenol results in decreased expression of BCL2L1 mRNA CTD PMID:24286936 isoprenaline decreases expression EXP 6480464 Isoproterenol results in decreased expression of BCL2L1 mRNA and Isoproterenol results in decreased expression of BCL2L1 protein CTD PMID:24286936 more ... isoprenaline increases expression EXP 6480464 Isoproterenol results in increased expression of BCL2L1 mRNA alternative form more ... CTD PMID:12738230 and PMID:16116328 isoprenaline multiple interactions EXP 6480464 Apigenin inhibits the reaction [Isoproterenol results in decreased expression of BCL2L1 protein] more ... CTD PMID:12738230 more ... isorhamnetin decreases expression ISO BCL2L1 (Homo sapiens) 6480464 3-methylquercetin results in decreased expression of BCL2L1 mRNA and 3-methylquercetin results in decreased expression of BCL2L1 protein CTD PMID:22992727 isotretinoin increases expression ISO BCL2L1 (Homo sapiens) 6480464 Isotretinoin results in increased expression of BCL2L1 mRNA and Isotretinoin results in increased expression of BCL2L1 protein CTD PMID:21159604 isotretinoin decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Isotretinoin results in decreased expression of BCL2L1 protein CTD PMID:16135400 kaempferol multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 kaempferol promotes the reaction [BBC3 protein binds to BCL2L1 protein] and TP53 protein affects the reaction [kaempferol promotes the reaction [BBC3 protein binds to BCL2L1 protein]] CTD PMID:19028473 kurarinol decreases expression ISO BCL2L1 (Homo sapiens) 6480464 kurarinol results in decreased expression of BCL2L1 mRNA and kurarinol results in decreased expression of BCL2L1 protein CTD PMID:24997323 kurarinol multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 kurarinol inhibits the reaction [STAT3 protein binds to BCL2L1 promoter] CTD PMID:24997323 kurarinol decreases expression ISO Bcl2l1 (Mus musculus) 6480464 kurarinol results in decreased expression of BCL2L1 mRNA and kurarinol results in decreased expression of BCL2L1 protein CTD PMID:24997323 kurarinol multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 kurarinol inhibits the reaction [STAT3 protein binds to BCL2L1 promoter] CTD PMID:24997323 L-ascorbic acid multiple interactions EXP 6480464 Ascorbic Acid inhibits the reaction [Potassium Dichromate results in decreased expression of BCL2L1 protein] and Ascorbic Acid inhibits the reaction [Streptozocin results in decreased expression of BCL2L1 protein] CTD PMID:18758938 and PMID:21262251 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency] results in decreased expression of BCL2L1 protein and geraniol inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in decreased expression of BCL2L1 protein] CTD PMID:26695085 lactacystin multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 lactacystin inhibits the reaction [Acetaminophen results in decreased expression of BCL2L1 protein] CTD PMID:15673306 lead diacetate affects expression ISO BCL2L1 (Homo sapiens) 6480464 lead acetate affects the expression of BCL2L1 protein CTD PMID:26542248 lead diacetate multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 HMOX1 protein affects the reaction [lead acetate affects the expression of BCL2L1 protein] CTD PMID:26542248 lead(0) multiple interactions EXP 6480464 Grape Seed Proanthocyanidins inhibits the reaction [Lead results in decreased expression of BCL2L1 protein] CTD PMID:29630945 lead(0) decreases expression EXP 6480464 Lead results in decreased expression of BCL2L1 protein CTD PMID:29630945 leptomycin B multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 leptomycin B inhibits the reaction [Tretinoin results in decreased expression of BCL2L1 protein] CTD PMID:14592536 linalool decreases expression ISO BCL2L1 (Homo sapiens) 6480464 linalool results in decreased expression of BCL2L1 mRNA CTD PMID:28567457 lipoic acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide co-treated with Thioctic Acid] results in decreased expression of BCL2L1 mRNA CTD PMID:23830814 lipopolysaccharide multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 (+)-JQ1 compound inhibits the reaction [Lipopolysaccharides results in increased expression of BCL2L1 mRNA] more ... CTD PMID:18789402 and PMID:25725100 lipopolysaccharide multiple interactions EXP 6480464 MIR16 inhibits the reaction [Lipopolysaccharides results in decreased expression of BCL2L1 protein] CTD PMID:31777165 lipopolysaccharide decreases expression EXP 6480464 Lipopolysaccharides results in decreased expression of BCL2L1 protein CTD PMID:31777165 lipopolysaccharide increases expression ISO Bcl2l1 (Mus musculus) 6480464 Lipopolysaccharides results in increased expression of BCL2L1 mRNA and Lipopolysaccharides results in increased expression of BCL2L1 protein CTD PMID:18789402 and PMID:23107598 lipopolysaccharide multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Lipopolysaccharides results in increased expression of BCL2L1 protein] more ... CTD PMID:18789402 more ... lipopolysaccharide increases expression ISO BCL2L1 (Homo sapiens) 6480464 Lipopolysaccharides results in increased expression of BCL2L1 mRNA CTD PMID:25725100 lithium chloride increases expression ISO BCL2L1 (Homo sapiens) 6480464 Lithium Chloride results in increased expression of BCL2L1 mRNA and Lithium Chloride results in increased expression of BCL2L1 protein CTD PMID:19101580 and PMID:22493441 lithocholic acid increases expression ISO Bcl2l1 (Mus musculus) 6480464 Lithocholic Acid results in increased expression of BCL2L1 mRNA CTD PMID:19433268 lithocholic acid multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 1 more ... CTD PMID:19433268 lonafarnib multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 lonafarnib promotes the reaction [Bortezomib results in increased cleavage of BCL2L1 protein] CTD PMID:16118318 lonidamine decreases expression ISO BCL2L1 (Homo sapiens) 6480464 lonidamine results in decreased expression of BCL2L1 protein CTD PMID:21889928 lovastatin decreases expression EXP 6480464 Lovastatin results in decreased expression of BCL2L1 protein CTD PMID:11178870 lovastatin multiple interactions EXP 6480464 Mevalonic Acid inhibits the reaction [Lovastatin results in decreased expression of BCL2L1 protein] CTD PMID:11178870 lutein increases expression ISO BCL2L1 (Homo sapiens) 6480464 Lutein results in increased expression of BCL2L1 protein CTD PMID:10750663 luteolin decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Luteolin results in decreased expression of BCL2L1 protein CTD PMID:21601631 luteolin multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 Luteolin inhibits the reaction [chromium hexavalent ion results in increased expression of BCL2L1 protein] CTD PMID:25448439 Luteolin 7-methyl ether decreases expression EXP 6480464 hydroxygenkwanin results in decreased expression of BCL2L1 protein CTD PMID:24144774 luteolin 7-O-beta-D-glucoside decreases expression ISO BCL2L1 (Homo sapiens) 6480464 luteolin-7-glucoside results in decreased expression of BCL2L1 protein CTD PMID:34165247 LY294002 multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [N(6)-cyclopentyladenosine results in increased expression of BCL2L1 protein] and 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [salvianolic acid B inhibits the reaction [Arsenic Trioxide results in decreased expression of BCL2L1 protein]] CTD PMID:23201927 and PMID:35901927 LY294002 decreases expression ISO BCL2L1 (Homo sapiens) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of BCL2L1 protein CTD PMID:14762343 and PMID:21173233 LY294002 increases degradation ISO BCL2L1 (Homo sapiens) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased degradation of BCL2L1 protein CTD PMID:21821001 LY294002 multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Lipopolysaccharides results in increased expression of BCL2L1 protein] and 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rottlerin inhibits the reaction [trimethyltin results in decreased expression of BCL2L1 protein]] CTD PMID:18789402 and PMID:25895139 LY294002 multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Lipopolysaccharides results in increased expression of BCL2L1 protein] more ... CTD PMID:18789402 more ... maneb multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [Paraquat co-treated with Maneb] results in decreased expression of BCL2L1 protein CTD PMID:15824117 maneb increases expression ISO BCL2L1 (Homo sapiens) 6480464 Maneb results in increased expression of BCL2L1 mRNA CTD PMID:18266926 manganese atom multiple interactions EXP 6480464 [Manganese co-treated with NGF protein] results in decreased expression of BCL2L1 protein and PPM1D protein inhibits the reaction [[Manganese co-treated with NGF protein] results in decreased expression of BCL2L1 protein] CTD PMID:25791630 manganese atom decreases expression EXP 6480464 Manganese results in decreased expression of BCL2L1 protein CTD PMID:25791630 manganese(0) multiple interactions EXP 6480464 [Manganese co-treated with NGF protein] results in decreased expression of BCL2L1 protein and PPM1D protein inhibits the reaction [[Manganese co-treated with NGF protein] results in decreased expression of BCL2L1 protein] CTD PMID:25791630 manganese(0) decreases expression EXP 6480464 Manganese results in decreased expression of BCL2L1 protein CTD PMID:25791630 manganese(II) chloride decreases expression EXP 6480464 manganese chloride results in decreased expression of BCL2L1 protein CTD PMID:27107493 mangiferin decreases expression ISO BCL2L1 (Homo sapiens) 6480464 mangiferin results in decreased expression of BCL2L1 protein CTD PMID:21547680 and PMID:26996543 melamine decreases expression ISO BCL2L1 (Homo sapiens) 6480464 melamine results in decreased expression of BCL2L1 protein CTD PMID:22915474 melatonin multiple interactions EXP 6480464 Melatonin inhibits the reaction [Indomethacin results in decreased expression of BCL2L1 mRNA] CTD PMID:19220725 melatonin multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 Melatonin promotes the reaction [Puromycin results in decreased expression of BCL2L1 protein] CTD PMID:21244482 mercaptopurine decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Mercaptopurine results in decreased expression of BCL2L1 protein CTD PMID:12697733 mercury dichloride increases expression EXP 6480464 Mercuric Chloride results in increased expression of BCL2L1 mRNA CTD PMID:8872981 metformin multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 Cisplatin promotes the reaction [Metformin results in decreased expression of BCL2L1 protein] CTD PMID:21388661 metformin multiple interactions EXP 6480464 Metformin inhibits the reaction [Streptozocin results in increased expression of BCL2L1 mRNA] CTD PMID:35414346 metformin decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Metformin results in decreased expression of BCL2L1 protein CTD PMID:21388661 methamphetamine affects expression EXP 6480464 Methamphetamine affects the expression of BCL2L1 mRNA alternative form CTD PMID:10336889 methamphetamine multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 EPHX1 protein affects the reaction [Methamphetamine results in decreased expression of BCL2L1 protein] and PRKCD protein affects the reaction [Methamphetamine results in decreased expression of BCL2L1 protein] CTD PMID:31422080 methamphetamine decreases expression ISO Bcl2l1 (Mus musculus) 6480464 Methamphetamine results in decreased expression of BCL2L1 protein CTD PMID:31422080 methamphetamine increases methylation ISO Bcl2l1 (Mus musculus) 6480464 Methamphetamine results in increased methylation of BCL2L1 promoter CTD PMID:26307267 methamphetamine increases expression ISO Bcl2l1 (Mus musculus) 6480464 Methamphetamine results in increased expression of BCL2L1 mRNA CTD PMID:26307267 methamphetamine decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Methamphetamine results in decreased expression of BCL2L1 mRNA CTD PMID:23820845 methamphetamine multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [N-Methyl-3 and 4-methylenedioxyamphetamine co-treated with Methamphetamine co-treated with 4-methylthioamphetamine co-treated with Dextroamphetamine] results in decreased expression of BCL2L1 mRNA CTD PMID:23820845 methidathion increases expression ISO Bcl2l1 (Mus musculus) 6480464 methidathion results in increased expression of BCL2L1 mRNA CTD PMID:34813904 methotrexate increases expression ISO BCL2L1 (Homo sapiens) 6480464 Methotrexate results in increased expression of BCL2L1 mRNA CTD PMID:21678067 methoxychlor increases expression ISO Bcl2l1 (Mus musculus) 6480464 Methoxychlor results in increased expression of BCL2L1 mRNA CTD PMID:20829426 and PMID:23000595 methylmercury chloride decreases expression EXP 6480464 methylmercuric chloride results in decreased expression of BCL2L1 protein CTD PMID:28821999 methylmercury(1+) multiple interactions EXP 6480464 [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of BCL2L1 mRNA CTD PMID:17905399 methylparaben increases expression ISO BCL2L1 (Homo sapiens) 6480464 methylparaben results in increased expression of BCL2L1 mRNA and methylparaben results in increased expression of BCL2L1 protein CTD PMID:24481588 metoprolol multiple interactions EXP 6480464 Metoprolol inhibits the reaction [Isoproterenol results in increased expression of BCL2L1 protein] CTD PMID:12738230 mevalonic acid multiple interactions EXP 6480464 Mevalonic Acid inhibits the reaction [Lovastatin results in decreased expression of BCL2L1 protein] CTD PMID:11178870 mifepristone multiple interactions EXP 6480464 Mifepristone affects the reaction [Dexamethasone inhibits the reaction [Camptothecin results in decreased expression of BCL2L1 protein alternative form]] more ... CTD PMID:15755911 more ... mitomycin C decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Mitomycin results in decreased expression of BCL2L1 mRNA CTD PMID:18615204 mitomycin C increases expression ISO BCL2L1 (Homo sapiens) 6480464 Mitomycin results in increased expression of BCL2L1 protein CTD PMID:11867586 mitoxantrone multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 BCL2L1 protein inhibits the reaction [Mitoxantrone results in increased activity of CASP3 protein] and BCL2L1 protein inhibits the reaction [Mitoxantrone results in increased degradation of PARP1 protein] CTD PMID:8840993 mono(2-ethylhexyl) phthalate multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 AKT1 protein affects the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of BCL2L1 mRNA] and AKT1 protein affects the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of BCL2L1 protein] CTD PMID:18755736 mono(2-ethylhexyl) phthalate increases expression ISO Bcl2l1 (Mus musculus) 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of BCL2L1 mRNA and mono-(2-ethylhexyl)phthalate results in increased expression of BCL2L1 protein CTD PMID:18755736 monocrotaline multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of BCL2L1 mRNA CTD PMID:21224054 morin decreases expression ISO BCL2L1 (Homo sapiens) 6480464 morin results in decreased expression of BCL2L1 mRNA CTD PMID:28689916 morin multiple interactions EXP 6480464 morin inhibits the reaction [Streptozocin results in increased expression of BCL2L1 mRNA] CTD PMID:35414346 morphine decreases expression EXP 6480464 Morphine results in decreased expression of BCL2L1 mRNA CTD PMID:15183518 morusin decreases expression ISO BCL2L1 (Homo sapiens) 6480464 morusin results in decreased expression of BCL2L1 protein CTD PMID:33035517 Myrtucommulone A decreases expression ISO Bcl2l1 (Mus musculus) 6480464 myrtucommulone A results in decreased expression of BCL2L1 mRNA CTD PMID:26032814 N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 N more ... CTD PMID:19887557 N,N-dimethylformamide multiple interactions EXP 6480464 [Dimethylformamide co-treated with Carbon Tetrachloride] results in decreased expression of BCL2L1 protein CTD PMID:20097184 N,N-dimethylformamide increases expression ISO BCL2L1 (Homo sapiens) 6480464 Dimethylformamide results in increased expression of BCL2L1 protein CTD PMID:29984871 N,N-dimethylformamide multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 Thiocarbamates analog inhibits the reaction [Dimethylformamide results in decreased expression of BCL2L1 protein] CTD PMID:29984871 N-(6-acetamidohexyl)acetamide affects expression ISO BCL2L1 (Homo sapiens) 6480464 hexamethylene bisacetamide affects the expression of BCL2L1 CTD PMID:15543656 N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide promotes the reaction [BAD protein binds to BCL2L1 protein] CTD PMID:12629175 N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl)cyclohexanecarboxamide multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide inhibits the reaction [8-Hydroxy-2-(di-n-propylamino)tetralin results in decreased expression of BCL2L1 protein] CTD PMID:30366073 N-acetyl-L-cysteine multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 Acetylcysteine inhibits the reaction [[Sulindac co-treated with Arsenic Trioxide] results in increased phosphorylation of BCL2L1 protein] more ... CTD PMID:18281123 more ... N-acetyl-L-cysteine multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 Acetylcysteine inhibits the reaction [3-Pyridinecarboxylic acid more ... CTD PMID:37308051 N-acetyl-L-cysteine multiple interactions EXP 6480464 Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in decreased expression of BCL2L1 protein] and Acetylcysteine inhibits the reaction [Carboplatin results in decreased expression of BCL2L1 protein] CTD PMID:18483861 and PMID:22085843 N-Acetyl-S-(1,2-dichlorovinyl)-cysteine affects expression ISO BCL2L1 (Homo sapiens) 6480464 S-1 and 2-dichlorovinyl-N-acetylcysteine affects the expression of BCL2L1 mRNA CTD PMID:16844155 N-acetylsphingosine multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 LGALS3 inhibits the reaction [N-acetylsphingosine results in increased degradation of BCL2L1 protein] CTD PMID:21821001 N-acetylsphingosine increases degradation ISO BCL2L1 (Homo sapiens) 6480464 N-acetylsphingosine results in increased degradation of BCL2L1 protein CTD PMID:21821001 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Arachidonic Acid results in decreased expression of BCL2L1 protein] CTD PMID:19540902 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal decreases expression ISO BCL2L1 (Homo sapiens) 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of BCL2L1 protein CTD PMID:16960866 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Topotecan results in increased degradation of BCL2L1 protein] CTD PMID:19812371 N-ethyl-N-nitrosourea increases expression ISO Bcl2l1 (Mus musculus) 6480464 Ethylnitrosourea results in increased expression of BCL2L1 mRNA CTD PMID:30944280 N-methyl-4-phenylpyridinium increases expression ISO BCL2L1 (Homo sapiens) 6480464 1-Methyl-4-phenylpyridinium results in increased expression of BCL2L1 mRNA CTD PMID:18266926 N-methyl-4-phenylpyridinium multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 Curcumin inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2L1 protein] CTD PMID:30463061 N-methyl-4-phenylpyridinium decreases expression ISO BCL2L1 (Homo sapiens) 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of BCL2L1 protein CTD PMID:24810058 and PMID:30463061 N-methyl-4-phenylpyridinium multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 [CD47 protein binds to SIRPA protein] inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2L1 protein] and NSC 23766 inhibits the reaction [[CD47 protein binds to SIRPA protein] inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2L1 protein]] CTD PMID:28268219 N-methyl-4-phenylpyridinium decreases expression ISO Bcl2l1 (Mus musculus) 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of BCL2L1 protein CTD PMID:28268219 N-methyl-4-phenylpyridinium multiple interactions EXP 6480464 ML 9 inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2L1 protein] more ... CTD PMID:24358303 N-methyl-4-phenylpyridinium decreases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of BCL2L1 protein CTD PMID:24358303 N-methyl-N'-nitro-N-nitrosoguanidine multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 BCL2L1 protein results in decreased susceptibility to [Methylnitronitrosoguanidine co-treated with veliparib] CTD PMID:18376143 N-methyl-N'-nitro-N-nitrosoguanidine increases expression ISO Bcl2l1 (Mus musculus) 6480464 Methylnitronitrosoguanidine results in increased expression of BCL2L1 mRNA CTD PMID:20434464 N-methyl-N'-nitro-N-nitrosoguanidine multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in increased expression of BCL2L1 mRNA] CTD PMID:20434464 N-nitrosodiethylamine increases expression ISO Bcl2l1 (Mus musculus) 127285675 N-nitrosodiethylamine increases expression of Bcl2l1 mRNA in liver RGD N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of BCL2L1 mRNA and Diethylnitrosamine results in increased expression of BCL2L1 protein CTD PMID:21167192 more ... N-nitrosodiethylamine increases expression ISO Bcl2l1 (Mus musculus) 6480464 Diethylnitrosamine results in increased expression of BCL2L1 mRNA CTD PMID:21607683 N-nitrosodiethylamine multiple interactions EXP 6480464 5 more ... CTD PMID:11749691 more ... N-nitrosodimethylamine multiple interactions EXP 6480464 Estradiol inhibits the reaction [Dimethylnitrosamine results in decreased expression of BCL2L1 protein] and idoxifene inhibits the reaction [Dimethylnitrosamine results in decreased expression of BCL2L1 protein] CTD PMID:14659978 N-nitrosodimethylamine decreases expression EXP 6480464 Dimethylnitrosamine results in decreased expression of BCL2L1 protein CTD PMID:14659978 NAD zwitterion multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 NAD inhibits the reaction [Acetaminophen results in decreased expression of BCL2L1 protein] CTD PMID:11461765 NAD(+) multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 NAD inhibits the reaction [Acetaminophen results in decreased expression of BCL2L1 protein] CTD PMID:11461765 nefazodone multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with nefazodone] results in increased expression of BCL2L1 mRNA CTD PMID:33819548 nickel dichloride increases expression ISO BCL2L1 (Homo sapiens) 6480464 nickel chloride results in increased expression of BCL2L1 protein CTD PMID:21837363 nickel dichloride decreases response to substance ISO BCL2L1 (Homo sapiens) 6480464 BCL2L1 protein results in decreased susceptibility to nickel chloride CTD PMID:23828460 nickel dichloride affects expression EXP 6480464 nickel chloride affects the expression of BCL2L1 mRNA CTD PMID:22546817 nickel dichloride decreases expression EXP 6480464 nickel chloride results in decreased expression of BCL2L1 protein CTD PMID:20391133 nickel subsulfide decreases expression ISO BCL2L1 (Homo sapiens) 6480464 nickel subsulfide results in decreased expression of BCL2L1 protein CTD PMID:20112989 nickel sulfate increases expression ISO BCL2L1 (Homo sapiens) 6480464 nickel sulfate results in increased expression of BCL2L1 protein CTD PMID:21776270 nickel sulfate decreases expression ISO BCL2L1 (Homo sapiens) 6480464 nickel sulfate results in decreased expression of BCL2L1 mRNA and nickel sulfate results in decreased expression of BCL2L1 protein CTD PMID:35499276 nickel sulfate multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 pyrazolanthrone inhibits the reaction [nickel sulfate results in decreased expression of BCL2L1 protein] CTD PMID:35499276 niclosamide multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [Niclosamide binds to Polyethyleneimine] which results in decreased expression of BCL2L1 mRNA more ... CTD PMID:20215516 more ... niclosamide decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Niclosamide analog results in decreased expression of BCL2L1 protein and Niclosamide results in decreased expression of BCL2L1 protein CTD PMID:26116531 more ... nicotine multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 resveratrol inhibits the reaction [Nicotine results in decreased expression of BCL2L1 mRNA] CTD PMID:22687363 nicotine decreases expression ISO Bcl2l1 (Mus musculus) 6480464 Nicotine results in decreased expression of BCL2L1 mRNA CTD PMID:22687363 nitric oxide decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Nitric Oxide results in decreased expression of BCL2L1 protein CTD PMID:15126337 nitric oxide increases expression EXP 6480464 Nitric Oxide results in increased expression of BCL2L1 mRNA CTD PMID:25726415 nitric oxide multiple interactions EXP 6480464 GATA5 protein promotes the reaction [Nitric Oxide inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2L1 mRNA]] more ... CTD PMID:25726415 nitrobenzenes decreases expression EXP 6480464 Nitrobenzenes analog results in decreased expression of BCL2L1 mRNA CTD PMID:19784758 nitrofen decreases expression ISO BCL2L1 (Homo sapiens) 6480464 nitrofen results in decreased expression of BCL2L1 protein CTD PMID:17439724 nitroprusside multiple interactions EXP 6480464 MAPK3 protein affects the susceptibility to [Nitroprusside results in decreased expression of BCL2L1 mRNA] and MAPK8 protein affects the susceptibility to [Nitroprusside results in decreased expression of BCL2L1 mRNA] CTD PMID:20132804 nitroprusside decreases expression EXP 6480464 Nitroprusside results in decreased expression of BCL2L1 mRNA and Nitroprusside results in decreased expression of BCL2L1 protein CTD PMID:20132804 Nodularin increases expression EXP 6480464 nodularin results in increased expression of BCL2L1 protein CTD PMID:25192816 Nor-9-carboxy-delta9-THC multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [Cannabinoids results in increased abundance of 11-nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid] which affects the methylation of BCL2L1 gene CTD PMID:30521419 NORCANTHARIDIN decreases expression ISO BCL2L1 (Homo sapiens) 6480464 norcantharidin results in decreased expression of BCL2L1 protein CTD PMID:21266192 and PMID:29193574 NSC 23766 multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 NSC 23766 inhibits the reaction [[CD47 protein binds to SIRPA protein] inhibits the reaction [1-Methyl-4-phenylpyridinium results in decreased expression of BCL2L1 protein]] CTD PMID:28268219 Nutlin-3 multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 nutlin 3 promotes the reaction [TP53 protein binds to BCL2L1 protein] CTD PMID:16014563 Nutlin-3 decreases expression ISO BCL2L1 (Homo sapiens) 6480464 nutlin 3 results in decreased expression of BCL2L1 protein CTD PMID:21109480 ochratoxin A decreases expression ISO BCL2L1 (Homo sapiens) 6480464 ochratoxin A results in decreased expression of BCL2L1 mRNA and ochratoxin A results in decreased expression of BCL2L1 protein CTD PMID:15056805 more ... ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of BCL2L1 mRNA CTD PMID:23208426 ochratoxin A decreases response to substance ISO BCL2L1 (Homo sapiens) 6480464 BCL2L1 protein results in decreased susceptibility to ochratoxin A CTD PMID:20549612 oleanolic acid multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [Oleanolic Acid analog binds to Succinic Acid] which results in decreased expression of BCL2L1 mRNA and [Oleanolic Acid analog binds to Succinic Acid] which results in decreased expression of BCL2L1 protein CTD PMID:31401087 oltipraz multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 [Lithocholic Acid co-treated with oltipraz] results in increased expression of BCL2L1 mRNA CTD PMID:19433268 ouabain decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Ouabain results in decreased expression of BCL2L1 protein CTD PMID:31436044 oxaliplatin decreases expression ISO BCL2L1 (Homo sapiens) 6480464 oxaliplatin results in decreased expression of BCL2L1 protein CTD PMID:16024531 oxybenzone decreases expression EXP 6480464 oxybenzone results in decreased expression of BCL2L1 mRNA CTD PMID:30316929 oxybuprocaine decreases expression ISO BCL2L1 (Homo sapiens) 6480464 benoxinate results in decreased expression of BCL2L1 protein CTD PMID:27590991 ozone multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [Aripiprazole co-treated with Ozone] results in increased expression of BCL2L1 mRNA CTD PMID:31476115 ozone multiple interactions EXP 6480464 [Air Pollutants results in increased abundance of Ozone] which results in increased expression of BCL2L1 mRNA CTD PMID:37088303 ozone increases expression ISO BCL2L1 (Homo sapiens) 6480464 Ozone results in increased expression of BCL2L1 mRNA CTD PMID:31476115 paclitaxel decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Paclitaxel results in decreased expression of BCL2L1 mRNA and Paclitaxel results in decreased expression of BCL2L1 protein CTD PMID:11774260 more ... paclitaxel multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [CXCL8 results in increased expression of BCL2L1 mRNA] which results in decreased susceptibility to Paclitaxel more ... CTD PMID:16051289 more ... paclitaxel decreases response to substance ISO BCL2L1 (Homo sapiens) 6480464 BCL2L1 protein results in decreased susceptibility to Paclitaxel CTD PMID:11468182 more ... paclitaxel increases phosphorylation ISO BCL2L1 (Homo sapiens) 6480464 Paclitaxel results in increased phosphorylation of BCL2L1 protein CTD PMID:18521433 paclitaxel increases expression ISO BCL2L1 (Homo sapiens) 6480464 Paclitaxel results in increased expression of BCL2L1 mRNA and Paclitaxel results in increased expression of BCL2L1 protein CTD PMID:10822281 paracetamol affects expression ISO BCL2L1 (Homo sapiens) 6480464 Acetaminophen affects the expression of BCL2L1 mRNA CTD PMID:11896290 paracetamol increases expression ISO Bcl2l1 (Mus musculus) 6480464 Acetaminophen results in increased expression of BCL2L1 mRNA and Acetaminophen results in increased expression of BCL2L1 protein CTD PMID:11264010 more ... paracetamol decreases expression ISO Bcl2l1 (Mus musculus) 6480464 Acetaminophen results in decreased expression of BCL2L1 protein CTD PMID:11461765 more ... paracetamol decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of BCL2L1 mRNA CTD PMID:21420995 paracetamol multiple interactions EXP 6480464 pyrazolanthrone inhibits the reaction [Acetaminophen results in increased expression of BCL2L1 protein modified form] and Taurine inhibits the reaction [Acetaminophen results in increased expression of BCL2L1 protein modified form] CTD PMID:20166895 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of BCL2L1 mRNA and Acetaminophen results in increased expression of BCL2L1 protein modified form CTD PMID:19784758 and PMID:20166895 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of BCL2L1 mRNA CTD PMID:19784758 and PMID:33387578 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of BCL2L1 mRNA CTD PMID:19784758 paracetamol affects expression ISO Bcl2l1 (Mus musculus) 6480464 Acetaminophen affects the expression of BCL2L1 mRNA CTD PMID:17562736 paracetamol multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 4-aminobenzamide inhibits the reaction [Acetaminophen results in decreased expression of BCL2L1 protein] more ... CTD PMID:10663392 more ... paraquat multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [Paraquat co-treated with Maneb] results in decreased expression of BCL2L1 protein CTD PMID:15824117 paraquat decreases expression EXP 6480464 Paraquat results in decreased expression of BCL2L1 protein CTD PMID:35707280 paraquat multiple interactions EXP 6480464 ginkgolide C inhibits the reaction [Paraquat results in decreased expression of BCL2L1 protein] CTD PMID:35707280 paraquat increases expression ISO BCL2L1 (Homo sapiens) 6480464 Paraquat results in increased expression of BCL2L1 mRNA and Paraquat results in increased expression of BCL2L1 protein CTD PMID:18056701 paraquat decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Paraquat results in decreased expression of BCL2L1 mRNA CTD PMID:18836921 paraquat affects expression EXP 6480464 Paraquat affects the expression of BCL2L1 mRNA CTD PMID:16854511 paraquat decreases response to substance EXP 6480464 BCL2L1 gene mutant form results in decreased susceptibility to Paraquat CTD PMID:10970895 paraquat increases expression ISO Bcl2l1 (Mus musculus) 6480464 Paraquat results in increased expression of BCL2L1 mRNA and Paraquat results in increased expression of BCL2L1 protein CTD PMID:12595580 and PMID:16797015 paraquat multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 GPX1 protein affects the reaction [Paraquat results in increased expression of BCL2L1 protein] CTD PMID:12654481 parathion decreases expression EXP 6480464 Parathion results in decreased expression of BCL2L1 mRNA CTD PMID:19784758 paricalcitol multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [paricalcitol co-treated with arsenic trioxide] results in decreased expression of BCL2L1 CTD PMID:15781666 parthenolide decreases response to substance ISO BCL2L1 (Homo sapiens) 6480464 BCL2L1 protein results in decreased susceptibility to parthenolide CTD PMID:16024633 PCB138 increases expression ISO Bcl2l1 (Mus musculus) 6480464 2 more ... CTD PMID:29704545 PCB138 multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 2 more ... CTD PMID:29704545 Pentoxifylline multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [Pentoxifylline co-treated with TNFSF10 protein] results in decreased expression of BCL2L1 protein CTD PMID:20804743 Pentoxifylline decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Pentoxifylline results in decreased expression of BCL2L1 mRNA and Pentoxifylline results in decreased expression of BCL2L1 protein CTD PMID:18851957 pepstatin A multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 pepstatin inhibits the reaction [Glucosamine results in decreased expression of BCL2L1 protein] CTD PMID:16850161 perfluorooctane-1-sulfonic acid multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of BCL2L1 mRNA and [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of BCL2L1 mRNA CTD PMID:36331819 perfluorooctanoic acid increases expression ISO BCL2L1 (Homo sapiens) 6480464 perfluorooctanoic acid results in increased expression of BCL2L1 protein CTD PMID:26879310 perfluorooctanoic acid multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [Plasticizers co-treated with Cosmetics co-treated with Flame Retardants co-treated with perfluorooctanoic acid co-treated with Phytoestrogens] results in increased expression of BCL2L1 mRNA CTD PMID:33325755 perindopril multiple interactions EXP 6480464 Perindopril inhibits the reaction [Isoproterenol results in increased expression of BCL2L1 mRNA alternative form] CTD PMID:16116328 pevonedistat affects expression ISO BCL2L1 (Homo sapiens) 6480464 pevonedistat affects the expression of BCL2L1 mRNA CTD PMID:24634471 PHA-665752 decreases expression ISO BCL2L1 (Homo sapiens) 6480464 5-((2 more ... CTD PMID:20661229 phenethyl isothiocyanate decreases expression ISO BCL2L1 (Homo sapiens) 6480464 phenethyl isothiocyanate results in decreased expression of BCL2L1 protein CTD PMID:16054126 phenobarbital multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in decreased expression of BCL2L1 protein CTD PMID:11749691 phenobarbital multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 Phenobarbital inhibits the reaction [Lithocholic Acid results in increased expression of BCL2L1 mRNA] CTD PMID:19433268 phenol red multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of BCL2L1 protein CTD PMID:31629898 phenylephrine multiple interactions EXP 6480464 Phenylephrine inhibits the reaction [Doxorubicin results in decreased expression of BCL2L1 mRNA] more ... CTD PMID:11042672 and PMID:35979984 phenylephrine decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Phenylephrine results in decreased expression of BCL2L1 protein CTD PMID:31605733 phenylmercury acetate increases expression ISO BCL2L1 (Homo sapiens) 6480464 Phenylmercuric Acetate results in increased expression of BCL2L1 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BCL2L1 mRNA CTD PMID:27188386 phenytoin multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of BCL2L1 mRNA CTD PMID:21224054 phloretin multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 2 more ... CTD PMID:32408695 phlorizin multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 [2 more ... CTD PMID:32408695 phorbol 13-acetate 12-myristate increases expression ISO BCL2L1 (Homo sapiens) 6480464 Tetradecanoylphorbol Acetate results in increased expression of BCL2L1 protein CTD PMID:11139146 phorbol 13-acetate 12-myristate multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [indirubin-3'-monoxime co-treated with Tetradecanoylphorbol Acetate] results in increased expression of BCL2L1 mRNA CTD PMID:18958680 phytoestrogen multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [Plasticizers co-treated with Cosmetics co-treated with Flame Retardants co-treated with perfluorooctanoic acid co-treated with Phytoestrogens] results in increased expression of BCL2L1 mRNA CTD PMID:33325755 picoxystrobin decreases expression ISO BCL2L1 (Homo sapiens) 6480464 picoxystrobin results in decreased expression of BCL2L1 mRNA CTD PMID:33512557 picrotoxin decreases expression EXP 6480464 Picrotoxin results in decreased expression of BCL2L1 mRNA CTD PMID:15170462 pifithrin-? multiple interactions EXP 6480464 pifithrin inhibits the reaction [triptolide results in decreased expression of BCL2L1 protein] CTD PMID:30009776 pifithrin-? multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 [Puromycin Aminonucleoside co-treated with pifithrin] results in increased expression of BCL2L1 protein more ... CTD PMID:15987750 and PMID:21593185 pirinixic acid increases expression ISO Bcl2l1 (Mus musculus) 6480464 pirinixic acid results in increased expression of BCL2L1 mRNA and pirinixic acid results in increased expression of BCL2L1 protein CTD PMID:18445702 and PMID:20709802 pirinixic acid multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 [pirinixic acid results in increased expression of BCL2L1 protein] inhibits the reaction [Iron-Dextran Complex results in increased activity of CASP3 protein] CTD PMID:20709802 PK-11195 decreases expression ISO BCL2L1 (Homo sapiens) 6480464 PK 11195 results in decreased expression of BCL2L1 protein CTD PMID:15519653 platycodin D decreases expression ISO BCL2L1 (Homo sapiens) 6480464 platycodin D results in decreased expression of BCL2L1 protein CTD PMID:23236765 plumbagin decreases expression ISO BCL2L1 (Homo sapiens) 126925996 [Plumbagin alone or cotreated with IL-6] decreases expression of BCL2L1 mRNA in liver RGD potassium dichromate affects localization EXP 6480464 Potassium Dichromate affects the localization of BCL2L1 protein CTD PMID:21262251 potassium dichromate decreases expression EXP 6480464 Potassium Dichromate results in decreased expression of BCL2L1 protein CTD PMID:21262251 and PMID:37931768 potassium dichromate multiple interactions EXP 6480464 [6-chloro-2 more ... CTD PMID:21262251 and PMID:35307491 Pranoprofen decreases expression ISO BCL2L1 (Homo sapiens) 6480464 pyranoprofen results in decreased expression of BCL2L1 protein CTD PMID:31765691 pregnenolone 16alpha-carbonitrile multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 Pregnenolone Carbonitrile inhibits the reaction [Lithocholic Acid results in increased expression of BCL2L1 mRNA] CTD PMID:19433268 pregnenolone 16alpha-carbonitrile increases expression ISO Bcl2l1 (Mus musculus) 6480464 Pregnenolone Carbonitrile results in increased expression of BCL2L1 mRNA CTD PMID:28903501 prochloraz increases expression EXP 6480464 prochloraz results in increased expression of BCL2L1 mRNA CTD PMID:29038839 progesterone multiple interactions EXP 6480464 BCL2L1 mRNA affects the reaction [Progesterone inhibits the reaction [Doxorubicin results in increased activity of CASP3 protein]] and Mifepristone inhibits the reaction [Progesterone results in increased expression of BCL2L1 protein] CTD PMID:20726854 progesterone increases expression EXP 6480464 Progesterone results in increased expression of BCL2L1 mRNA and Progesterone results in increased expression of BCL2L1 protein CTD PMID:15941375 more ... progesterone affects response to substance EXP 6480464 BCL2L1 mRNA affects the susceptibility to Progesterone CTD PMID:20726854 promethazine decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Promethazine results in decreased expression of BCL2L1 protein CTD PMID:31682805 propiconazole decreases expression ISO Bcl2l1 (Mus musculus) 6480464 propiconazole results in decreased expression of BCL2L1 mRNA CTD PMID:21278054 propofol decreases expression EXP 6480464 Propofol results in decreased expression of BCL2L1 mRNA and Propofol results in decreased expression of BCL2L1 protein CTD PMID:26254736 propylparaben increases expression ISO BCL2L1 (Homo sapiens) 6480464 propylparaben results in increased expression of BCL2L1 mRNA and propylparaben results in increased expression of BCL2L1 protein CTD PMID:24481588 prostaglandin E2 multiple interactions EXP 6480464 Dinoprostone affects the reaction [Puromycin Aminonucleoside results in decreased expression of BCL2L1 protein] CTD PMID:16396944 protein kinase inhibitor decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Protein Kinase Inhibitors results in decreased expression of BCL2L1 protein CTD PMID:21173233 protein kinase inhibitor multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 Protein Kinase Inhibitors inhibits the reaction [Doxorubicin results in decreased expression of BCL2L1 protein] and Protein Kinase Inhibitors inhibits the reaction [MAP3K20 protein results in decreased expression of BCL2L1 protein] CTD PMID:29105997 Psymberin decreases response to substance ISO BCL2L1 (Homo sapiens) 6480464 BCL2L1 protein results in decreased susceptibility to psymberin CTD PMID:20920557 pterostilbene increases expression ISO Bcl2l1 (Mus musculus) 6480464 pterostilbene results in increased expression of BCL2L1 protein CTD PMID:20681671 pterostilbene multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 pterostilbene inhibits the reaction [sodium arsenite results in decreased expression of BCL2L1 protein] CTD PMID:31139082 pterostilbene decreases expression ISO BCL2L1 (Homo sapiens) 6480464 pterostilbene results in decreased expression of BCL2L1 protein CTD PMID:23313376 purine-6-thiol decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Mercaptopurine results in decreased expression of BCL2L1 protein CTD PMID:12697733 puromycin multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 Melatonin promotes the reaction [Puromycin results in decreased expression of BCL2L1 protein] CTD PMID:21244482 puromycin decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Puromycin results in decreased expression of BCL2L1 protein CTD PMID:21244482 pyrethrins increases expression ISO BCL2L1 (Homo sapiens) 6480464 Pyrethrins results in increased expression of BCL2L1 mRNA CTD PMID:35321623 pyrrolidine dithiocarbamate multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 pyrrolidine dithiocarbamic acid inhibits the reaction [Lipopolysaccharides results in increased expression of BCL2L1 protein] CTD PMID:18789402 pyrrolidine dithiocarbamate multiple interactions EXP 6480464 [Copper co-treated with pyrrolidine dithiocarbamic acid] results in decreased expression of BCL2L1 protein and Acetylcysteine inhibits the reaction [[Copper co-treated with pyrrolidine dithiocarbamic acid] results in decreased expression of BCL2L1 protein] CTD PMID:22085843 pyrrolidine dithiocarbamate multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 pyrrolidine dithiocarbamic acid inhibits the reaction [Lipopolysaccharides results in increased expression of BCL2L1 protein] CTD PMID:18789402 quercetin multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [arsenic trioxide co-treated with Quercetin] results in decreased expression of BCL2L1 protein more ... CTD PMID:16082193 more ... quercetin decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Quercetin results in decreased expression of BCL2L1 mRNA and Quercetin results in decreased expression of BCL2L1 protein CTD PMID:16049707 more ... quercetin multiple interactions EXP 6480464 Quercetin inhibits the reaction [Hydrogen Peroxide results in decreased expression of BCL2L1 protein] CTD PMID:14505808 quercetin multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 Quercetin inhibits the reaction [4-nitro-3-cresol results in decreased expression of BCL2L1 protein] more ... CTD PMID:17046822 more ... quercetin increases expression ISO BCL2L1 (Homo sapiens) 6480464 Quercetin results in increased expression of BCL2L1 protein CTD PMID:14688022 raloxifene decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Raloxifene Hydrochloride results in decreased expression of BCL2L1 protein CTD PMID:28430601 reactive oxygen species multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [[[CD40LG protein co-treated with IL4 protein] results in increased abundance of Reactive Oxygen Species] which results in increased expression of and results in increased phosphorylation of and results in increased stability of TP53 protein] which results in increased expression of BCL2L1 protein CTD PMID:27634759 Rebamipide increases expression ISO BCL2L1 (Homo sapiens) 6480464 rebamipide results in increased expression of BCL2L1 protein CTD PMID:29054700 Rebamipide multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rebamipide results in increased expression of BCL2L1 protein] more ... CTD PMID:29054700 resveratrol multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 6-chloro-2 more ... CTD PMID:21593185 more ... resveratrol increases expression ISO Bcl2l1 (Mus musculus) 6480464 resveratrol results in increased expression of BCL2L1 mRNA CTD PMID:23525482 resveratrol multiple interactions EXP 6480464 resveratrol inhibits the reaction [Testosterone results in increased expression of BCL2L1 protein] CTD PMID:25714330 resveratrol decreases expression ISO BCL2L1 (Homo sapiens) 6480464 resveratrol results in decreased expression of BCL2L1 mRNA and resveratrol results in decreased expression of BCL2L1 protein CTD PMID:11577002 more ... resveratrol decreases response to substance ISO BCL2L1 (Homo sapiens) 6480464 BCL2L1 protein results in decreased susceptibility to resveratrol CTD PMID:19561642 resveratrol increases expression ISO BCL2L1 (Homo sapiens) 6480464 resveratrol results in increased expression of BCL2L1 mRNA and resveratrol results in increased expression of BCL2L1 protein CTD PMID:12569576 and PMID:18089832 resveratrol affects localization EXP 6480464 resveratrol affects the localization of BCL2L1 protein CTD PMID:17984113 resveratrol decreases expression ISO Bcl2l1 (Mus musculus) 6480464 resveratrol results in decreased expression of BCL2L1 protein CTD PMID:17872969 resveratrol multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [clofarabine co-treated with resveratrol] inhibits the reaction [BCL2L1 mutant form results in increased expression of MCL1 protein] more ... CTD PMID:16546976 more ... rifampicin increases expression ISO BCL2L1 (Homo sapiens) 6480464 Rifampin results in increased expression of BCL2L1 protein CTD PMID:11958592 and PMID:12645856 rifampicin multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of BCL2L1 mRNA CTD PMID:21224054 ritonavir decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Ritonavir results in decreased expression of BCL2L1 mRNA CTD PMID:16174765 Ro 31-8220 multiple interactions EXP 6480464 Ro 31-8220 inhibits the reaction [Hexachlorocyclohexane results in increased expression of BCL2L1 protein] CTD PMID:22001173 romidepsin multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [romidepsin co-treated with Bortezomib] results in decreased expression of BCL2L1 protein CTD PMID:18223231 rotenone affects expression ISO Bcl2l1 (Mus musculus) 6480464 Rotenone affects the expression of BCL2L1 mRNA CTD PMID:23186747 rotenone decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Rotenone results in decreased expression of BCL2L1 mRNA CTD PMID:33512557 rottlerin decreases expression ISO BCL2L1 (Homo sapiens) 6480464 rottlerin results in decreased expression of BCL2L1 protein CTD PMID:22902833 rottlerin multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rottlerin inhibits the reaction [trimethyltin results in decreased expression of BCL2L1 protein]] more ... CTD PMID:25895139 more ... rubimaillin multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 BCL2L1 protein inhibits the reaction [rubimaillin results in increased activity of CASP12 protein] more ... CTD PMID:19716835 rucaparib affects response to substance ISO BCL2L1 (Homo sapiens) 6480464 BCL2L1 protein affects the susceptibility to rucaparib CTD PMID:32927276 rutin multiple interactions EXP 6480464 Rutin inhibits the reaction [Carbon Tetrachloride results in increased expression of BCL2L1 mRNA] CTD PMID:26062544 Salinomycin increases expression ISO BCL2L1 (Homo sapiens) 6480464 salinomycin results in increased expression of BCL2L1 mRNA CTD PMID:34806536 Salvianolic acid A multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 salvianolic acid A inhibits the reaction [Plant Extracts results in decreased expression of BCL2L1 protein] CTD PMID:23993977 Salvianolic acid A multiple interactions EXP 6480464 salvianolic acid A inhibits the reaction [arsenic trioxide results in decreased expression of BCL2L1 protein] CTD PMID:28391263 salvianolic acid B multiple interactions EXP 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [salvianolic acid B inhibits the reaction [arsenic trioxide results in decreased expression of BCL2L1 protein]] more ... CTD PMID:23201927 and PMID:24769256 salvianolic acid B increases expression EXP 6480464 salvianolic acid B results in increased expression of BCL2L1 protein CTD PMID:23201927 sarin decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Sarin results in decreased expression of BCL2L1 mRNA CTD PMID:19522546 sarin increases expression ISO BCL2L1 (Homo sapiens) 6480464 Sarin results in increased expression of BCL2L1 mRNA CTD PMID:19522546 SB 203580 multiple interactions EXP 6480464 SB 203580 promotes the reaction [Cisplatin results in decreased expression of BCL2L1 protein] CTD PMID:19578154 SB 431542 multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of BCL2L1 mRNA CTD PMID:27188386 SCH772984 multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 SCH772984 inhibits the reaction [pachastrissamine analog inhibits the reaction [BCL2L1 protein binds to BECN1 protein]] CTD PMID:35123989 scutellarin multiple interactions EXP 6480464 scutellarin inhibits the reaction [cobaltous chloride results in decreased expression of BCL2L1 mRNA] CTD PMID:18442013 Se-methyl-L-selenocysteine decreases expression ISO BCL2L1 (Homo sapiens) 6480464 selenomethylselenocysteine metabolite results in decreased expression of BCL2L1 mRNA CTD PMID:25321483 Se-methylselenocysteine decreases expression ISO BCL2L1 (Homo sapiens) 6480464 selenomethylselenocysteine metabolite results in decreased expression of BCL2L1 mRNA CTD PMID:25321483 selenium atom increases expression ISO BCL2L1 (Homo sapiens) 6480464 Selenium results in increased expression of BCL2L1 mRNA CTD PMID:19244175 selenium atom multiple interactions EXP 6480464 [Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of BCL2L1 mRNA CTD PMID:11444866 senecionine decreases expression ISO BCL2L1 (Homo sapiens) 6480464 senecionine results in decreased expression of BCL2L1 protein CTD PMID:29458164 sevoflurane decreases expression ISO Bcl2l1 (Mus musculus) 6480464 Sevoflurane results in decreased expression of BCL2L1 mRNA and Sevoflurane results in decreased expression of BCL2L1 protein CTD PMID:35350913 sevoflurane multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 alpha-solamargine inhibits the reaction [Sevoflurane results in decreased expression of BCL2L1 mRNA] and alpha-solamargine inhibits the reaction [Sevoflurane results in decreased expression of BCL2L1 protein] CTD PMID:35350913 sildenafil citrate multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 BCL2L1 protein inhibits the reaction [Sildenafil Citrate results in increased activity of Doxorubicin] and Sildenafil Citrate promotes the reaction [Doxorubicin results in decreased expression of BCL2L1 protein] CTD PMID:20884855 sildenafil citrate affects response to substance ISO BCL2L1 (Homo sapiens) 6480464 BCL2L1 protein affects the susceptibility to Sildenafil Citrate CTD PMID:20884855 silicon dioxide decreases expression ISO Bcl2l1 (Mus musculus) 6480464 Silicon Dioxide results in decreased expression of BCL2L1 protein CTD PMID:27616297 silicon dioxide decreases methylation ISO BCL2L1 (Homo sapiens) 6480464 Silicon Dioxide results in decreased methylation of BCL2L1 gene CTD PMID:34973136 silicon dioxide increases expression ISO BCL2L1 (Homo sapiens) 6480464 Silicon Dioxide results in increased expression of BCL2L1 mRNA CTD PMID:34766707 silicon dioxide increases expression ISO Bcl2l1 (Mus musculus) 6480464 Silicon Dioxide results in increased expression of BCL2L1 mRNA CTD PMID:29203145 silicon dioxide multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 HMGB1 protein promotes the reaction [Silicon Dioxide results in decreased expression of BCL2L1 protein] and neo-gambogic acid inhibits the reaction [Silicon Dioxide results in decreased expression of BCL2L1 protein] CTD PMID:27616297 simazine decreases expression ISO Bcl2l1 (Mus musculus) 6480464 Simazine results in decreased expression of BCL2L1 mRNA CTD PMID:25461544 simvastatin multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 Simvastatin inhibits the reaction [TNF protein results in increased expression of BCL2L1 protein] CTD PMID:17277159 simvastatin decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Simvastatin results in decreased expression of BCL2L1 protein CTD PMID:18521906 and PMID:20060890 sirolimus multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [7-hydroxystaurosporine co-treated with Sirolimus] results in decreased expression of BCL2L1 protein more ... CTD PMID:15767555 more ... sirolimus increases expression ISO Bcl2l1 (Mus musculus) 6480464 Sirolimus results in increased expression of BCL2L1 mRNA and Sirolimus results in increased expression of BCL2L1 protein CTD PMID:18097008 and PMID:21681844 sirolimus decreases expression ISO Bcl2l1 (Mus musculus) 6480464 Sirolimus results in decreased expression of BCL2L1 mRNA and Sirolimus results in decreased expression of BCL2L1 protein CTD PMID:19922502 sirolimus multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 [Sirolimus co-treated with IL2 protein] results in increased expression of BCL2L1 mRNA and Sirolimus inhibits the reaction [Lipopolysaccharides results in increased expression of BCL2L1 protein] CTD PMID:11355896 and PMID:18789402 sirolimus decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Sirolimus results in decreased expression of BCL2L1 protein CTD PMID:15782132 sodium arsenate multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of BCL2L1 mRNA CTD PMID:32525701 sodium arsenite multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] which co-treated with Benzo(a)pyrene] results in increased expression of BCL2L1 protein more ... CTD PMID:24570342 more ... sodium arsenite affects expression ISO BCL2L1 (Homo sapiens) 6480464 sodium arsenite affects the expression of BCL2L1 mRNA CTD PMID:29319823 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of BCL2L1 protein CTD PMID:19616567 sodium arsenite multiple interactions EXP 6480464 Taurine inhibits the reaction [sodium arsenite results in decreased expression of BCL2L1 protein] and Taurine inhibits the reaction [sodium arsenite results in increased expression of BCL2L1 protein alternative form] CTD PMID:19616567 and PMID:20830294 sodium arsenite affects localization ISO Bcl2l1 (Mus musculus) 6480464 sodium arsenite affects the localization of BCL2L1 protein CTD PMID:16166651 sodium arsenite decreases expression ISO Bcl2l1 (Mus musculus) 6480464 sodium arsenite results in decreased expression of BCL2L1 mRNA CTD PMID:16014739 sodium arsenite increases expression ISO Bcl2l1 (Mus musculus) 6480464 sodium arsenite results in increased expression of BCL2L1 mRNA CTD PMID:17451858 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of BCL2L1 protein CTD PMID:20830294 sodium arsenite decreases expression ISO BCL2L1 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of BCL2L1 mRNA and sodium arsenite results in decreased expression of BCL2L1 protein CTD PMID:12760830 more ... sodium arsenite increases expression ISO BCL2L1 (Homo sapiens) 6480464 sodium arsenite results in increased expression of BCL2L1 mRNA and sodium arsenite results in increased expression of BCL2L1 protein CTD PMID:24431212 and PMID:24570342 sodium chromate decreases expression ISO BCL2L1 (Homo sapiens) 6480464 sodium chromate(VI) results in decreased expression of BCL2L1 mRNA CTD PMID:14971655 sodium dichromate decreases expression ISO Bcl2l1 (Mus musculus) 6480464 sodium bichromate results in decreased expression of BCL2L1 protein CTD PMID:20298709 sodium dichromate multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 FBP1 protein inhibits the reaction [sodium bichromate results in increased expression of BCL2L1 protein] CTD PMID:28624442 sodium dichromate increases expression ISO BCL2L1 (Homo sapiens) 6480464 sodium bichromate results in increased expression of BCL2L1 protein CTD PMID:28624442 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of BCL2L1 mRNA CTD PMID:12325037 sodium dichromate affects expression EXP 6480464 sodium bichromate affects the expression of BCL2L1 mRNA CTD PMID:11960910 sodium dichromate multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 CAT protein inhibits the reaction [sodium bichromate results in decreased expression of BCL2L1 protein] and TRP53 mutant form inhibits the reaction [sodium bichromate results in decreased expression of BCL2L1 protein] CTD PMID:20298709 sorafenib multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [sorafenib co-treated with TNFSF10 protein] results in decreased expression of BCL2L1 protein more ... CTD PMID:17909059 more ... sorafenib decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Sorafenib results in decreased expression of BCL2L1 protein CTD PMID:16109713 more ... spironolactone increases expression EXP 6480464 Spironolactone results in increased expression of BCL2L1 protein CTD PMID:19114643 stattic multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 stattic inhibits the reaction [glycine-extended gastrin 17 results in increased expression of BCL2L1 mRNA] CTD PMID:19153190 staurosporine affects expression EXP 6480464 Staurosporine affects the expression of BCL2L1 mRNA CTD PMID:11296547 staurosporine increases expression ISO BCL2L1 (Homo sapiens) 6480464 Staurosporine results in increased expression of BCL2L1 protein alternative form CTD PMID:21256112 staurosporine decreases response to substance EXP 6480464 BCL2L1 gene mutant form results in decreased susceptibility to Staurosporine CTD PMID:10970895 staurosporine decreases response to substance ISO Bcl2l1 (Mus musculus) 6480464 BCL2L1 protein results in decreased susceptibility to Staurosporine CTD PMID:10679475 staurosporine decreases response to substance ISO BCL2L1 (Homo sapiens) 6480464 BCL2L1 protein results in decreased susceptibility to Staurosporine CTD PMID:11468182 stavudine increases expression EXP 6480464 Stavudine results in increased expression of BCL2L1 mRNA CTD PMID:18299183 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of BCL2L1 protein CTD PMID:15976052 and PMID:19682444 streptozocin decreases expression ISO Bcl2l1 (Mus musculus) 6480464 Streptozocin results in decreased expression of BCL2L1 mRNA CTD PMID:24781736 streptozocin decreases expression EXP 6480464 Streptozocin results in decreased expression of BCL2L1 mRNA and Streptozocin results in decreased expression of BCL2L1 protein CTD PMID:16595661 more ... streptozocin multiple interactions EXP 6480464 Anthocyanins inhibits the reaction [Streptozocin results in decreased expression of BCL2L1 protein] more ... CTD PMID:16595661 more ... styrene increases expression ISO BCL2L1 (Homo sapiens) 6480464 Styrene results in increased expression of BCL2L1 protein CTD PMID:16705669 styrene oxide increases expression ISO BCL2L1 (Homo sapiens) 6480464 styrene oxide results in increased expression of BCL2L1 protein CTD PMID:16705669 succimer multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of BCL2L1 mRNA and [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of BCL2L1 mRNA CTD PMID:21641980 and PMID:26378955 succinic acid multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [Oleanolic Acid analog binds to Succinic Acid] which results in decreased expression of BCL2L1 mRNA and [Oleanolic Acid analog binds to Succinic Acid] which results in decreased expression of BCL2L1 protein CTD PMID:31401087 sulforaphane multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 sulforaphane inhibits the reaction [sulforaphane results in decreased expression of BCL2L1 protein] CTD PMID:21684301 sulforaphane decreases expression ISO BCL2L1 (Homo sapiens) 6480464 sulforaphane results in decreased expression of BCL2L1 protein CTD PMID:26833863 sulforaphane decreases expression ISO Bcl2l1 (Mus musculus) 6480464 sulforaphane results in decreased expression of BCL2L1 protein CTD PMID:21684301 sulindac multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [Sulindac co-treated with arsenic trioxide] results in increased phosphorylation of BCL2L1 protein more ... CTD PMID:18281123 sulindac decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Sulindac results in decreased expression of BCL2L1 protein CTD PMID:11062132 sulindac sulfide decreases expression ISO BCL2L1 (Homo sapiens) 6480464 sulindac sulfide results in decreased expression of BCL2L1 protein CTD PMID:11912124 Sunset Yellow FCF multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in increased expression of BCL2L1 mRNA CTD PMID:33819548 surfactin decreases expression ISO BCL2L1 (Homo sapiens) 6480464 surfactin peptide results in decreased expression of BCL2L1 protein CTD PMID:34850538 surfactin C decreases expression ISO BCL2L1 (Homo sapiens) 6480464 surfactin peptide results in decreased expression of BCL2L1 protein CTD PMID:34850538 T-2 toxin decreases expression ISO Bcl2l1 (Mus musculus) 6480464 T-2 Toxin results in decreased expression of BCL2L1 mRNA and T-2 Toxin results in decreased expression of BCL2L1 protein CTD PMID:29432840 T-2 toxin affects expression EXP 6480464 T-2 Toxin affects the expression of BCL2L1 protein CTD PMID:29413859 tacrolimus hydrate multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 Tacrolimus inhibits the reaction [Superantigens results in increased expression of BCL2L1 protein] CTD PMID:10532544 tamoxifen multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with Tamoxifen] results in decreased expression of BCL2L1 mRNA and [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with Tamoxifen] results in decreased expression of BCL2L1 protein CTD PMID:22046442 tanespimycin decreases expression ISO BCL2L1 (Homo sapiens) 6480464 tanespimycin results in decreased expression of BCL2L1 protein CTD PMID:16923571 tartrazine multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Tartrazine] results in increased expression of BCL2L1 mRNA CTD PMID:33819548 taurine multiple interactions EXP 6480464 Taurine inhibits the reaction [Acetaminophen results in increased expression of BCL2L1 protein modified form] more ... CTD PMID:19616567 more ... tauroursodeoxycholic acid decreases expression EXP 6480464 ursodoxicoltaurine results in decreased expression of BCL2L1 mRNA CTD PMID:12721362 Tautomycin multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 tautomycin inhibits the reaction [[Ibuprofen co-treated with epigallocatechin gallate] results in decreased expression of BCL2L1 mRNA alternative form] and tautomycin inhibits the reaction [[Ibuprofen co-treated with epigallocatechin gallate] results in increased expression of BCL2L1 mRNA alternative form] CTD PMID:18348186 temozolomide multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 MGMT protein affects the reaction [BCL2L1 protein affects the susceptibility to temozolomide] CTD PMID:16405512 TEMPO multiple interactions EXP 6480464 TEMPO inhibits the reaction [Hexachlorocyclohexane results in increased expression of BCL2L1 protein] CTD PMID:22001173 TEMPO decreases expression ISO Bcl2l1 (Mus musculus) 6480464 TEMPO results in decreased expression of BCL2L1 protein CTD PMID:25882087 teriflunomide decreases expression ISO BCL2L1 (Homo sapiens) 6480464 teriflunomide results in decreased expression of BCL2L1 mRNA CTD PMID:29427785 tert-butyl hydroperoxide multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 Plant Extracts inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2L1 protein] more ... CTD PMID:26102008 and PMID:27050144 tert-butyl hydroperoxide decreases expression EXP 6480464 tert-Butylhydroperoxide results in decreased expression of BCL2L1 protein CTD PMID:15569404 tert-butyl hydroperoxide multiple interactions EXP 6480464 Curcumin inhibits the reaction [tert-Butylhydroperoxide results in decreased expression of BCL2L1 protein] CTD PMID:15569404 tert-butyl hydroperoxide decreases expression ISO BCL2L1 (Homo sapiens) 6480464 tert-Butylhydroperoxide results in decreased expression of BCL2L1 mRNA and tert-Butylhydroperoxide results in decreased expression of BCL2L1 protein CTD PMID:12419474 more ... testosterone increases expression EXP 6480464 Testosterone results in increased expression of BCL2L1 mRNA and Testosterone results in increased expression of BCL2L1 protein CTD PMID:23500659 and PMID:25714330 testosterone multiple interactions EXP 6480464 Finasteride inhibits the reaction [Testosterone results in increased expression of BCL2L1 protein] and resveratrol inhibits the reaction [Testosterone results in increased expression of BCL2L1 protein] CTD PMID:25714330 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of BCL2L1 mRNA and Carbon Tetrachloride results in increased expression of BCL2L1 protein CTD PMID:16038630 and PMID:26062544 tetrachloromethane increases expression ISO Bcl2l1 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of BCL2L1 mRNA CTD PMID:25747392 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of BCL2L1 mRNA CTD PMID:19784758 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of BCL2L1 mRNA CTD PMID:12734012 tetrachloromethane multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 alisol B 23-acetate promotes the reaction [Carbon Tetrachloride results in increased expression of BCL2L1 mRNA] more ... CTD PMID:18038451 and PMID:25747392 tetrachloromethane multiple interactions EXP 6480464 [Carbon Tetrachloride co-treated with TM4SF4 protein] results in decreased expression of BCL2L1 mRNA more ... CTD PMID:17069928 more ... tetramethylpyrazine multiple interactions EXP 6480464 tetramethylpyrazine inhibits the reaction [Gentamicins results in decreased expression of BCL2L1 protein] CTD PMID:17132701 tetramethylpyrazine multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 tetramethylpyrazine inhibits the reaction [sodium arsenite results in decreased expression of BCL2L1 protein] CTD PMID:26404762 thalidomide decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Thalidomide results in decreased expression of BCL2L1 protein CTD PMID:15986355 thapsigargin multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 BCL2L1 protein inhibits the reaction [Thapsigargin results in increased expression of ERN1 protein] and BCL2L1 protein inhibits the reaction [Thapsigargin results in increased expression of XBP1 protein alternative form] CTD PMID:23885834 thapsigargin multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 4-(3-3 more ... CTD PMID:30841431 thapsigargin decreases expression ISO Bcl2l1 (Mus musculus) 6480464 Thapsigargin results in decreased expression of BCL2L1 protein CTD PMID:30841431 thapsigargin affects splicing EXP 6480464 Thapsigargin affects the splicing of BCL2L1 mRNA CTD PMID:25762722 thapsigargin affects splicing ISO Bcl2l1 (Mus musculus) 6480464 Thapsigargin affects the splicing of BCL2L1 mRNA CTD PMID:25762722 thapsigargin increases expression EXP 6480464 Thapsigargin results in increased expression of BCL2L1 protein CTD PMID:25762722 thapsigargin multiple interactions EXP 6480464 6-(bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2H-pyran-2-one inhibits the reaction [Thapsigargin affects the splicing of BCL2L1 mRNA] more ... CTD PMID:25762722 Theaflavin 3,3'-digallate decreases expression ISO BCL2L1 (Homo sapiens) 6480464 theaflavin-3 and 3'-digallate results in decreased expression of BCL2L1 protein CTD PMID:30769778 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of BCL2L1 mRNA CTD PMID:19784758 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of BCL2L1 mRNA CTD PMID:34492290 thioacetamide multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Thioacetamide co-treated with Thioctic Acid] results in decreased expression of BCL2L1 mRNA CTD PMID:23830814 thiostrepton decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Thiostrepton results in decreased expression of BCL2L1 mRNA CTD PMID:22321511 Thiotepa increases expression ISO BCL2L1 (Homo sapiens) 6480464 Thiotepa results in increased expression of BCL2L1 protein CTD PMID:10822281 thymol multiple interactions EXP 6480464 Thymol inhibits the reaction [Isoproterenol results in decreased expression of BCL2L1 mRNA] CTD PMID:26996544 thymol sulfate(1-) multiple interactions EXP 6480464 Thymol inhibits the reaction [Isoproterenol results in decreased expression of BCL2L1 mRNA] CTD PMID:26996544 thymoquinone decreases expression ISO BCL2L1 (Homo sapiens) 6480464 thymoquinone results in decreased expression of BCL2L1 protein CTD PMID:29981725 more ... tin(II) chloride (anhydrous) multiple interactions EXP 6480464 [stannous chloride results in increased activity of HMOX1 protein] which results in increased expression of BCL2L1 protein CTD PMID:16959961 titanium dioxide decreases expression ISO BCL2L1 (Homo sapiens) 6480464 titanium dioxide results in decreased expression of BCL2L1 mRNA CTD PMID:19486931 titanium dioxide increases expression ISO Bcl2l1 (Mus musculus) 6480464 titanium dioxide results in increased expression of BCL2L1 mRNA CTD PMID:23409001 and PMID:27760801 tocopherol decreases response to substance ISO BCL2L1 (Homo sapiens) 6480464 BCL2L1 protein results in decreased susceptibility to Tocopherols CTD PMID:16001965 Tomentosin multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 Acetylcysteine inhibits the reaction [tomentosin results in decreased expression of BCL2L1 protein] CTD PMID:30917517 Tomentosin decreases expression ISO BCL2L1 (Homo sapiens) 6480464 tomentosin results in decreased expression of BCL2L1 protein CTD PMID:30917517 toosendanin decreases expression ISO BCL2L1 (Homo sapiens) 6480464 toosendanin analog results in decreased expression of BCL2L1 protein and toosendanin results in decreased expression of BCL2L1 protein CTD PMID:34742683 topotecan multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 APAF1 promotes the reaction [Topotecan results in increased degradation of BCL2L1 protein] more ... CTD PMID:19812371 topotecan increases degradation ISO Bcl2l1 (Mus musculus) 6480464 Topotecan results in increased degradation of BCL2L1 protein CTD PMID:19812371 tributylstannane multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 PRKCD gene mutant form inhibits the reaction [tributyltin results in decreased expression of BCL2L1 protein] CTD PMID:25895139 Tributyltin oxide decreases expression ISO Bcl2l1 (Mus musculus) 6480464 bis(tri-n-butyltin)oxide results in decreased expression of BCL2L1 mRNA CTD PMID:22434021 Tributyltin oxide decreases expression ISO BCL2L1 (Homo sapiens) 6480464 bis(tri-n-butyltin)oxide results in decreased expression of BCL2L1 mRNA CTD PMID:21601586 trichloroethene multiple interactions EXP 6480464 [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of BCL2L1 mRNA CTD PMID:17905399 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of BCL2L1 mRNA CTD PMID:33387578 trichostatin A multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 BCL2L1 protein results in decreased susceptibility to [Bortezomib co-treated with trichostatin A] more ... CTD PMID:16904634 and PMID:19887557 trichostatin A affects expression ISO BCL2L1 (Homo sapiens) 6480464 trichostatin A affects the expression of BCL2L1 mRNA CTD PMID:28542535 trichostatin A decreases expression EXP 6480464 trichostatin A results in decreased expression of BCL2L1 mRNA CTD PMID:23558232 trichostatin A decreases expression ISO BCL2L1 (Homo sapiens) 6480464 trichostatin A results in decreased expression of BCL2L1 protein CTD PMID:16009488 and PMID:19887557 trichostatin A decreases response to substance EXP 6480464 BCL2L1 gene mutant form results in decreased susceptibility to trichostatin A CTD PMID:10970895 trichostatin A decreases response to substance ISO BCL2L1 (Homo sapiens) 6480464 BCL2L1 protein results in decreased susceptibility to trichostatin A CTD PMID:15781649 triclosan decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Triclosan results in decreased expression of BCL2L1 mRNA CTD PMID:34681664 trimethyltin decreases expression ISO Bcl2l1 (Mus musculus) 6480464 trimethyltin results in decreased expression of BCL2L1 protein CTD PMID:25895139 trimethyltin multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rottlerin inhibits the reaction [trimethyltin results in decreased expression of BCL2L1 protein]] and rottlerin inhibits the reaction [trimethyltin results in decreased expression of BCL2L1 protein] CTD PMID:25895139 Triptolide increases expression ISO Bcl2l1 (Mus musculus) 6480464 triptolide results in increased expression of BCL2L1 protein CTD PMID:26990902 Triptolide multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 TRP53 gene mutant form inhibits the reaction [triptolide results in decreased expression of BCL2L1 protein] CTD PMID:30009776 Triptolide decreases expression ISO Bcl2l1 (Mus musculus) 6480464 triptolide results in decreased expression of BCL2L1 protein CTD PMID:30009776 Triptolide multiple interactions EXP 6480464 pifithrin inhibits the reaction [triptolide results in decreased expression of BCL2L1 protein] CTD PMID:30009776 Triptolide decreases expression EXP 6480464 triptolide results in decreased expression of BCL2L1 protein CTD PMID:30009776 triptonide decreases expression ISO Bcl2l1 (Mus musculus) 6480464 triptonide results in decreased expression of BCL2L1 mRNA CTD PMID:33045310 troglitazone decreases expression ISO BCL2L1 (Homo sapiens) 6480464 troglitazone results in decreased expression of BCL2L1 mRNA and troglitazone results in decreased expression of BCL2L1 protein CTD PMID:12680223 and PMID:19631733 troglitazone increases expression ISO Bcl2l1 (Mus musculus) 6480464 Troglitazone results in increased expression of BCL2L1 mRNA CTD PMID:31294483 tunicamycin decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Tunicamycin results in decreased expression of BCL2L1 mRNA CTD PMID:22378314 Tylophorine increases expression ISO BCL2L1 (Homo sapiens) 6480464 tylophorine analog results in increased expression of BCL2L1 mRNA CTD PMID:19284764 tyrphostin AG 1478 decreases expression EXP 6480464 RTKI cpd results in decreased expression of BCL2L1 mRNA and RTKI cpd results in decreased expression of BCL2L1 protein CTD PMID:18371937 valproic acid decreases methylation ISO BCL2L1 (Homo sapiens) 6480464 Valproic Acid results in decreased methylation of BCL2L1 gene CTD PMID:29154799 valproic acid decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of BCL2L1 protein CTD PMID:22814014 valproic acid increases expression ISO BCL2L1 (Homo sapiens) 6480464 Valproic Acid results in increased expression of BCL2L1 mRNA CTD PMID:19101580 more ... valproic acid multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 ABT-737 inhibits the reaction [BCL2L1 protein results in decreased susceptibility to Valproic Acid] CTD PMID:19060243 valproic acid decreases response to substance ISO Bcl2l1 (Mus musculus) 6480464 BCL2L1 protein results in decreased susceptibility to Valproic Acid CTD PMID:19060243 veliparib multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 BCL2L1 protein results in decreased susceptibility to [Methylnitronitrosoguanidine co-treated with veliparib] CTD PMID:18376143 vemurafenib multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [(+)-JQ1 compound co-treated with vemurafenib] results in decreased expression of BCL2L1 mRNA CTD PMID:27169980 venetoclax multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [mivebresib co-treated with venetoclax] results in decreased expression of BCL2L1 protein CTD PMID:30647404 venetoclax decreases expression ISO BCL2L1 (Homo sapiens) 6480464 venetoclax results in decreased expression of BCL2L1 protein CTD PMID:30647404 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of BCL2L1 mRNA CTD PMID:23034163 vincristine increases expression ISO BCL2L1 (Homo sapiens) 6480464 Vincristine results in increased expression of BCL2L1 mRNA CTD PMID:23649840 vincristine affects response to substance ISO BCL2L1 (Homo sapiens) 6480464 BCL2L1 protein affects the susceptibility to Vincristine CTD PMID:22178383 vitamin E multiple interactions EXP 6480464 [Selenium deficiency co-treated with Vitamin E deficiency] results in decreased expression of BCL2L1 mRNA CTD PMID:11444866 vitamin E increases expression ISO BCL2L1 (Homo sapiens) 6480464 Vitamin E results in increased expression of BCL2L1 mRNA CTD PMID:19244175 vorinostat multiple interactions EXP 6480464 [vorinostat co-treated with MYC protein] results in decreased expression of BCL2L1 mRNA and [vorinostat co-treated with MYC protein] results in decreased expression of BCL2L1 protein CTD PMID:17331788 vorinostat decreases response to substance ISO Bcl2l1 (Mus musculus) 6480464 BCL2L1 protein results in decreased susceptibility to vorinostat CTD PMID:19060243 vorinostat increases expression ISO BCL2L1 (Homo sapiens) 6480464 vorinostat results in increased expression of BCL2L1 mRNA alternative form and vorinostat results in increased expression of BCL2L1 protein alternative form CTD PMID:17351739 vorinostat multiple interactions ISO Bcl2l1 (Mus musculus) 6480464 ABT-737 inhibits the reaction [BCL2L1 protein results in decreased susceptibility to vorinostat] CTD PMID:19060243 vorinostat decreases expression ISO BCL2L1 (Homo sapiens) 6480464 vorinostat results in decreased expression of BCL2L1 mRNA more ... CTD PMID:15897598 more ... vorinostat decreases response to substance ISO BCL2L1 (Homo sapiens) 6480464 BCL2L1 results in decreased susceptibility to vorinostat CTD PMID:10597302 vorinostat decreases expression EXP 6480464 vorinostat results in decreased expression of BCL2L1 protein CTD PMID:18310471 vorinostat multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [(+)-JQ1 compound co-treated with vorinostat] results in decreased expression of BCL2L1 protein more ... CTD PMID:12446442 more ... wortmannin multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 wortmannin inhibits the reaction [Hydrogen Peroxide inhibits the reaction [arsenic trioxide results in decreased expression of BCL2L1 protein]] CTD PMID:15142122 Xanthorrhizol decreases expression ISO BCL2L1 (Homo sapiens) 6480464 xanthorrhizol results in decreased expression of BCL2L1 protein CTD PMID:34664399 zerumbone decreases expression ISO BCL2L1 (Homo sapiens) 6480464 zerumbone results in decreased expression of BCL2L1 mRNA CTD PMID:16007145 zinc atom decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Zinc results in decreased expression of BCL2L1 protein CTD PMID:16472982 zinc atom multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 Zinc inhibits the reaction [N more ... CTD PMID:19887557 zinc atom increases expression EXP 6480464 Zinc results in increased expression of BCL2L1 mRNA CTD PMID:17074742 zinc dichloride multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [Citric Acid co-treated with zinc chloride] results in decreased expression of BCL2L1 protein CTD PMID:16624386 zinc protoporphyrin multiple interactions EXP 6480464 zinc protoporphyrin inhibits the reaction [cobaltiprotoporphyrin results in increased expression of BCL2L1 protein] CTD PMID:20357190 zinc protoporphyrin increases expression ISO BCL2L1 (Homo sapiens) 6480464 zinc protoporphyrin results in increased expression of BCL2L1 protein CTD PMID:27829220 zinc pyrithione decreases expression ISO BCL2L1 (Homo sapiens) 6480464 pyrithione zinc results in decreased expression of BCL2L1 mRNA CTD PMID:21424779 zinc sulfate increases expression EXP 6480464 Zinc Sulfate results in increased expression of BCL2L1 mRNA CTD PMID:17074742 zinc sulfate multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 [Zinc Sulfate binds to azilsartan] which results in decreased expression of BCL2L1 protein CTD PMID:29408668 zinc(0) decreases expression ISO BCL2L1 (Homo sapiens) 6480464 Zinc results in decreased expression of BCL2L1 protein CTD PMID:16472982 zinc(0) increases expression EXP 6480464 Zinc results in increased expression of BCL2L1 mRNA CTD PMID:17074742 zinc(0) multiple interactions ISO BCL2L1 (Homo sapiens) 6480464 Zinc inhibits the reaction [N more ... CTD PMID:19887557 zoledronic acid increases expression ISO BCL2L1 (Homo sapiens) 6480464 zoledronic acid results in increased expression of BCL2L1 mRNA CTD PMID:19036117 zolmitriptan multiple interactions EXP 6480464 zolmitriptan inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2L1 mRNA] and zolmitriptan inhibits the reaction [Diethylnitrosamine results in increased expression of BCL2L1 protein] CTD PMID:31129132